Tag: atopic

41 PALLETS 3129 CARTONS PH ARMACEUTICALS AS UNDER CARV EDILOL TAB 12.5MG 100 NDC COD E:68462016401 FDA PRODUCT COD E NO :62 O C A 22 HTS NO.300 4.90.9221 ANDA NO.78-251 THE RAPEUTICE USE:-BETA- ADRENOA MNBU0552050 001 CEPTOR ANTAGONIST TELMISAR TAN-HCTZ TAB 80MG/25MG 30UD N DC CODE:68462084213 62 O D A 09 3004.90.92.20 202544 TEL MISARTAN AND HYDROCHLOROTHIAZ IDE TABLETS ARE INDICATED FOR THE TREATMENT OF HYPERTENS ION, TO LOWER BLOOD PRESSURE. MNBU0552050 001 TOPIRAMATE ER CAP (Q) 200M G 30 NDC CODE:68462037130 30 04.49.00.20 61 M C B 40 2102 78 COLESEVELAM HCL TAB 625M G 180 NDC CODE:68462043318 F DA PRODUCT CODE NO.: 62 B D A 13 H. T. S NO.: 3004.49.00. 10 ANDA NO.: 203480 THERAPEU MNBU0552050 001 TICE USE: - ANTIHYPERLIPO PR OTEINEMIC. TELMISARTAN-HCTZ TAB 80MG/12.5MG 30UD NDC COD E:68462084113 62 O D A 09 30 04.90.92.20 202544 TELMISART AN AND HYDROCHLOROTHIAZIDE T ABLETS ARE INDICATED FOR THE TREATMENT OF HYPERTENSION, T MNBU0552050 001 O LOWER BLOOD PRESSURE. CA RVEDILOL TAB 12.5MG 500 NDC C ODE:68462016405 FDA PRODUCT C ODE NO :62 O C A 22 HTS NO.3 004.90.9221 ANDA NO.78-251 T HERAPEUTICE USE:-BETA- ADREN OACEPTOR ANTAGONIST SEVELA MER HCL TAB 800MG 180 NDC COD MNBU0552050 001 E:68462044718 FDA PRODUCT COD E NO.: 63 L D A 04 H. T. S N O.: 3004.90.92.60 ANDA NO.:2 04724 THERAPEUTICE USE:SEVEL AMER HYDROCHLORIDE TABLETS A RE A PHOSPHATE BINDER INDICAT ED FOR THE CONTROL OF SERUM P HOSPHORUS IN PATIENTS WITH CH MNBU0552050 001 RONIC KIDNEY DISEASE ON DIAL YSIS DILTIAZEM HCL ER CAP 1 2HR 90MG 100 NDC CODE:6846208 5101 62 O C B 24 3004.49.00. 10 212317 FOR THE TREATMENT OF HYPERTENSION. TACROLIMU S OINT 0.1% 60GM NDC CODE:684 62053465 FDA PRODUCT CODE NO. MNBU0552050 001 : 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 21039 3 THERAPEUTICE USE: - TACROL IMUS IS A TOPICAL IMMUNOSUPPR ESSIVE OINTMENT USED FOR THE TREATMENT OF MODERATE-TO-SEV ERE ATOPIC DERMATITIS (ECZEM A). PIMECROLIMUS CREAM 1% 6 MNBU0552050 001 0GM NDC CODE:68462060965 FDA PRODUCT CODE NO.: 61 S C J 0 4 H. T. S NO.: 3004.90.92.45 ANDA NO.: 211769 THERAPEUTI CE USE: - AS SECOUND-LINE THE RAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC TRERTME NT OF MILD TO MODERATE ATOPIC MNBU0552050 001 DERMATITIS IN NONIMMUNOCOMP ROMISED ADULT AND CHILDREN 2 YEARS OF AGE SIROLIMUS TAB 1MG 100 NDC CODE:68462068301 FDA PRODUCT CODE NO.: 64 T C A 12 H. T. S NO.: 3004.90. 92.15 ANDA NO.: 208691 THERA PEUTICE USE: TO PREVENT REJEC MNBU0552050 001 TION OF KIDNEY TRANSPLANTS. PIMECROLIMUS CREAM 1% 30GM NDC CODE:68462060935 FDA PROD UCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 AND A NO.: 211769 THERAPEUTICE US E: - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-C MNBU0552050 001 ONTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DER MATITIS IN NONIMMUNOCOMPROMIS ED ADULT AND CHILDREN 2 YEAR S OF AGE COMMERCIAL & CUSTO M INVOICE NO. F22587000467 DT . 19.06.2024 F22587000468 DT. 19.06.2024 F22587000469 DT. MNBU0552050 001 19.06.2024 F22587000470 DT. 1 9.06.2024 F22587000471 DT. 19 .06.2024 S/BILL NO: 4010175 D T:20/06/2024 S/BILL NO: 40101 73 DT:20/06/2024 S/BILL NO: 4 010169 DT:20/06/2024 S/BILL N O: 4010170 DT:20/06/2024 S/BI LL NO: 4010172 DT:20/06/2024 MNBU0552050 001 NET WT. 6362.223 KGS 02 DATA LOGGERS HUMIDITY:65% SET TE MPERATURE : +18 DEGREES TEMPE RATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA

PEDIATRIC ATOPIC SKIN CREM A

26 PALLETS 1504 CARTONS PH ARMACEUTICALS AS UNDER TACR OLIMUS OINT 0.1% 100GM NDC CO DE:68462053494 FDA PRODUCT CO DE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE: - MNBU0419069 001 TACROLIMUS IS A TOPICAL IMMUN OSUPPRESSIVE OINTMENT USED FO R THE TREATMENT OF MODERATE- TO-SEVERE ATOPIC DERMATITIS (ECZEMA). CLINDAMYCIN HCL C AP 150MG 100 NDC CODE:6846201 4301 FDA PRODUCT CODE NO.:56 J C E 20 H. T. S NO.: 2941. MNBU0419069 001 90.5000 ANDA NO.:216957 THER APEUTICE USE: :#TREATMENT OF NUMEROUS INFECTIONS, INCLUDIN G BUT NOT LIMITED TO SEPTIC EMIA,INTRAABDOMINAL INFECTION S, LOWER RESPIRATORY INFECTI ONS, GYNECOLOGICAL INFECTIONS , BONE AND JOINT INFECTIONS, MNBU0419069 001 AND SKIN AND SKIN STRUCTURE INFECTIONS POTASSIUM CL ER CAP 10MEQ 100 NDC CODE:684620 35701 FDA PRODUCT CODE NO.:6 5 R C F 14 H. T. S NO.: 3004 .90.92.90 ANDA NO.:202868 TH ERAPEUTICE USE: - TREATMENT O R PREVENTION OF HYPOKALEMIA MNBU0419069 001 GABAPENTIN TAB 600MG 500 N DC CODE:68462012605 FDA PRODU CT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 ANDA NO.:-77 -662 THERAPEUTICE USE:-ANTIC ONVULSANT GABAPENTIN TAB 60 0MG 500 NDC CODE:68462012605 FDA PRODUCT CODE:NO : 61 N C MNBU0419069 001 A 69 HTS NO.3004.90.9236 AN DA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT EZETIMI BE TAB 10MG 500 NDC CODE:6846 2022605 FDA PRODUCT CODE NO.: 61 J C A 15 H. T. S NO.: 3 004.49.00.10 ANDA NO.: #07856 0 THERAPEUTICE USE: LIPID LO MNBU0419069 001 WERING AGENT GABAPENTIN TAB 600MG 500 NDC CODE:684620126 05 FDA PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 ANDA NO.:-77-662 THERAPEUTIC E USE:-ANTICONVULSANT COMM ERCIAL & CUSTOM INVOICE NO. F 22487002437 DT. 31.03.2024 F2 MNBU0419069 001 2487002440 DT. 31.03.2024 F22 487002441 DT. 31.03.2024 F224 87002446 DT. 31.03.2024 F2248 7002447 DT. 31.03.2024 F22487 002449 DT. 31.03.2024 S/BILL NO: 4005655 DT: 02/04/2024 S/ BILL NO: 4005654 DT: 02/04/202 4 S/BILL NO: 4005653 DT: 02/0 MNBU0419069 001 4/2024 S/BILL NO: 4005652 DT: 02/04/2024 S/BILL NO: 400565 0 DT: 02/04/2024 S/BILL NO: 4 005649 DT: 02/04/2024 NET WT. 4339.144 KGS DATA LOGGERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORPO MNBU0419069 001 RATE DRIVE, NEW JERSEY MAHWA H - 07430 USA

42 PALLETS 2227 CARTONS PH ARMACEUTICALS AS UNDER RANO LAZINE ER TAB 500MG 60 NDC CO DE:68462031960 FDA PRODUCT CO DE NO.: 61 D C B 02 H. T. S NO.: 3004.49.00.10 ANDA NO.: 211082 THERAPEUTIC USE: - IT MNBU3754230 001 IS AN ANTI-ANGINAL MEDICATIO N. IT WORKS BY IMPROVING BLOO D FLOW TO HELP THE HEART WORK MORE EFFICIENTLY. IT IS USED TO TREAT CHRONIC ANGINA (CH EST PAIN). IT IS NOT FOR USE DURING AN ACUTE (EMERGENCY) A TTACK OF ANGINA EZETIMIBE- MNBU3754230 001 SIMVA TAB 10/80MG 30 NDC CODE :68462032430 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO .: 3004.49.00.10 ANDA NO.: 2 08699 THERAPEUTICE USE: - THI S COMBINATION MEDICATION IS USED TO HELP LOWER BAD CHOLES TEROL AND FATS (SUCH AS LDL, MNBU3754230 001 TRIGLYCERIDES) AND RAISE GOO D CHOLESTEROL (HDL) IN THE BL OOD. EZETIMIBE WORKS BY REDUC ING THE AMOUNT OF CHOLESTEROL YOUR BODY ABSORBS FROM YOUR DIET. SIMVASTATIN BELONGS TO A GROUP OF DRUGS KNOWN AS "S TATINS." IT WORKS BY REDUCING MNBU3754230 001 THE AMOUNT OF CHOLESTEROL M ADE BY THE LIVER. CARVEDILO L TAB 25MG 500 NDC CODE:68462 016505 FDA PRODUCT CODE NO : 62 O C A 22 HTS NO.3004.90.92 21 ANDA NO.78-251 THERAPEUTI CE USE:-BETA- ADRENOACEPTOR ANTAGONIST RANOLAZINE ER T MNBU3754230 001 AB 500MG 60 NDC CODE:68462031 960 FDA PRODUCT CODE NO.: 61 D C B 02 H. T. S NO.: 3004. 49.00.10 ANDA NO.:211082 THE RAPEUTIC USE: - IT IS AN ANTI -ANGINAL MEDICATION. IT WORKS BY IMPROVING BLOOD FLOW TO HELP THE HEART WORK MORE EFFI MNBU3754230 001 CIENTLY. IT IS USED TO TREAT CHRONIC ANGINA (CHEST PAIN). IT IS NOT FOR USE DURING AN A CUTE (EMERGENCY) ATTACK OF A NGINA CARVEDILOL TAB 25MG 5 00 NDC CODE:68462016505 FDA PRODUCT CODE NO :62 O C A 22 HTS NO.3004.90.9221 ANDA NO. MNBU3754230 001 78-251 THERAPEUTICE USE:-BET A- ADRENOACEPTOR ANTAGONIST CARVEDILOL TAB 25MG 100 ND C CODE:68462016501 FDA PRODUC T CODE NO :62 O C A 22 HTS N O.3004.90.9221 ANDA NO.78-251 THERAPEUTICE USE:-BETA- AD RENOACEPTOR ANTAGONIST TER MNBU3754230 001 IFLUNOMIDE TAB 7MG 30 NDC COD E:68462042330 FDA PRODUCT COD E NO.: 60 L C A 99 H. T. S NO.:3004.90.9215 ANDA NO.: 20 9663 THERAPEUTICE USE: :#MUL TIPLE SCLEROSIS AGENT TACR OLIMUS OINT 0.1% 100GM NDC CO DE:68462053494 FDA PRODUCT CO MNBU3754230 001 DE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUN OSUPPRESSIVE OINTMENT USED FO R THE TREATMENT OF MODERATE- TO-SEVERE ATOPIC DERMATITIS (ECZEMA). SIROLIMUS TAB 1MG MNBU3754230 001 100 NDC CODE:68462068301 FD A PRODUCT CODE NO.: 64 T C A 12 H. T. S NO.: 3004.90.92.1 5 ANDA NO.: 208691 THERAPEUT ICE USE: TO PREVENT REJECTION OF KIDNEY TRANSPLANTS. AP REPITANT CAP 40MG 1UD NDC COD E:68462058340 FDA PRODUCT COD MNBU3754230 001 E NO.: 61 T C E 32 H. T. S N O.: 3004.90.92.40 ANDA NO.: 207777 THERAPEUTICE USE: -AP REPITANT IS USED WITH OTHER M EDICATIONS TO HELP PREVENT NA USEA AND VOMITING CAUSED BY CANCER DRUG TREATMENT (CHEMOT HERAPY). THIS MEDICATION IS A MNBU3754230 001 LSO USED TO PREVENT NAUSEA AN D VOMITING AFTER SURGERY. A- EMETIC/NAUSEANT / HUMAN - RX/ SINGLE INGREDIENT / DELAYED RELEASE TABLETS / APREPITANT COMMERCIAL & CUSTOM INVOICE NO. F22487002342 DT. 20.03.2 024 F22487002345 DT. 21.03.20 MNBU3754230 001 24 F22487002346 DT. 21.03.202 4 F22487002347 DT. 21.03.2024 F22487002348 DT. 21.03.2024 S/BILL NO: 4004831 DT: 21/03/ 2024 S/BILL NO: 4004832 DT: 2 1/03/2024 S/BILL NO: 4004833 DT: 21/03/2024 S/BILL NO: 400 4834 DT: 21/03/2024 S/BILL NO MNBU3754230 001 : 4004835 DT: 21/03/2024 GROS S WT. 10,515.652 NET WT.7695 .876 13 DATA LOGGERS SE T TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK PHAR MACEUTICALS INC 750, CORPORAT E DRIVE, NEW JERSEY MAHWAH - 07430 USA NOTIFY PARTY:3 G MNBU3754230 001 LENMARK SPECIALTY S.A. SWITZE RLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLAND

TACROLIMUS OINT 2994 CARTONS PHARMACEUTICALS AS UNDER TACROLIMUS OINT 0.1% 30GM NDC CODE 68462053435 FDA PRODUCT CODE NO. 64 T C J 08 HLBU9826507 001 H. T. S NO. 3004.49.00.50 ANDA NO. 210393 THERAPEUTICE USE - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF HLBU9826507 001 MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). TACROLIMUS OINT 0.1% 30GM NDC CODE 68462053435 FDA PRODUCT CODE NO. 64 T C J 08 H. T. S NO. HLBU9826507 001 3004.49.00.50 ANDA NO. 210393 THERAPEUTICE USE - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERATE-TO-SEVERE HLBU9826507 001 ATOPIC DERMATITIS (ECZEMA). EZETIMIBE TAB 10MG 500 NDC CODE 68462022605 FDA PRODUCT CODE NO. 61 J C A 15 H. T. S NO. 3004.49.00.10 HLBU9826507 001 ANDA NO. 078560 THERAPEUTICE USE LIPID LOWERING AGENT DILTIAZEM HCL ER CAP 12HR 90MG 100 NDC CODE 68462085101 62 O C B 24 3004.49.00.10 HLBU9826507 001 212317 FOR THE TREATMENT OF HYPERTENSION. EZETIMIBE TAB 10MG 90 NDC CODE 68462022690 FDA PRODUCT CODE NO. 61 J C A 15 H. T. S NO. HLBU9826507 001 3004.49.00.10 ANDA NO. 078560 THERAPEUTICE USE LIPID LOWERING AGENT EZETIMIBE-SIMVA TAB 10/20MG 90 NDC CODE 68462032290 FDA PRODUCT CODE NO. 61 J D C 15 HLBU9826507 001 H. T. S NO. 3004.49.00.10 ANDA NO. 208699 THERAPEUTICE USE LIPID LOWERING AGENT TACROLIMUS OINT 0.1% 30GM NDC CODE 68462053435 FDA PRODUCT CODE NO. HLBU9826507 001 64 T C J 08 H. T. S NO. 3004.49.00.50 ANDA NO. 210393 THERAPEUTICE USE - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT USED FOR THE HLBU9826507 001 TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). EZETIMIBE TAB 10MG 90 NDC CODE 68462022690 FDA PRODUCT CODE NO. 61 J C A 15 HLBU9826507 001 H. T. S NO. 3004.49.00.10 ANDA NO. 078560 THERAPEUTICE USE LIPID LOWERING AGENT

TACROLIMUS OINT 0.1% 488 CARTONS PHARMACEUTICALS AS UNDER TACROLIMUS OINT 0.1% 100GM NDC CODE 68462053494 HLBU9783370 001 FDA PRODUCT CODE NO. 62KCF10 HTS NO.3004.90.9255 ANDA NO. 91672 THERAPEUTICE USE -TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE HLBU9783370 001 VERAPAMIL HCL ER TAB 120MG 100 NDC CODE 68462029201 NDC NO. 68462029201 FDA PRODUCT CODE NO. 62 O C B 13 HTS NO.3004.90.9221 ANDA NO. 090700 HLBU9783370 001 THERAPEUTICE USE --ANGINA TOPIRAMATE TAB 25MG 500 NDC CODE 68462010805 FDA PRODUCT CODE NO. 61 M C A 40 H. T. S NO. 3004.49.00.20 HLBU9783370 001 ANDA NO. 077627 THERAPEUTICE USE ANTICONVULSANT TOPIRAMATE TAB 25MG 60 NDC CODE 68462010860 FDA PRODUCT CODE NO. -61 M C A 40 H. T. S NO. HLBU9783370 001 3004.49.00.20 ANDA NO. - 77-627 THERAPEUTICE USE -ANTICONVULSANT LITHIUM CARB ER TAB 450MG 100 NDC CODE 68462022401 FDA PRODUCT CODE NO. 61 N C B 37 HLBU9783370 001 H. T. S NO. 3004.49.00.20 ANDA NO. 91-616 THERAPEUTICE USE - INDICATED IN THE TREATMENT OF MANIC EPISODES OF BIPOLAR DISORDER. HLBU9783370 001 BIPOLAR DISORDER, MANIC (DSM-IV) IS EQUIVALENT TO MANIC DEPRESSIVE ILLNESS, MANIC, IN THE OLDER DSM-II TERMINOLOGY. ALSO INDICATED AS A MAINTENANCE TREATMENT FOR INDIVIDUALS HLBU9783370 001 WITH A DIAGNOSIS OF BIPOLAR DISORDER. MAINTENANCE THERAPY REDUCES THE FREQUENCY OF MANIC EPISODES AND DIMINISHES THE INTENSITY OF THOSE EPISODES WHICH HLBU9783370 001 MAY OCCUR. COMMERCIAL & CUSTOM INVOICE NO. F22452005990 DT. 06.03.2024 F22452005993 DT. 06.03.2024 F22452005991 DT. 06.03.2024 S/BILL NO 8133429 DT 07-MAR-2024 HLBU9783370 001 S/BILL NO 8133390 DT 07-MAR-2024 S/BILL NO 8133392 DT 07-MAR-2024 SCAC CODE YASV HBL NO BOM0062162 GROSS WT. 5,154.364 KGS NET WT.4092.619 KGS HLBU9783370 001 11 DATA LOGGERS HUMIDITY 65% HLBU9783370 002 FDA PRODUCT CODE NO. 64 T C J 08 H. T. S NO. 3004.49.00.50 ANDA NO. 210393 THERAPEUTICE USE - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE HLBU9783370 002 OINTMENT USED FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). TACROLIMUS OINT 0.1% 60GM NDC CODE 68462053465 HLBU9783370 002 FDA PRODUCT CODE NO. 64 T C J 08 H. T. S NO. 3004.49.00.50 ANDA NO. 210393 THERAPEUTICE USE - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE HLBU9783370 002 OINTMENT USED FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). PIMECROLIMUS CREAM 1% 30GM NDC CODE 68462060935 HLBU9783370 002 FDA PRODUCT CODE NO. 61 S C J 04 H. T. S NO. 3004.90.92.45 ANDA NO. 211769 THERAPEUTICE USE - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND HLBU9783370 002 NON-CONTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERMATITIS IN NON- IMMUNOCOMPROMISED ADULT AND CHILDREN 2 YEARS OF AGE HLBU9783370 002 PIMECROLIMUS CREAM 1% 60GM NDC CODE 68462060965 FDA PRODUCT CODE NO. 61 S C J 04 H. T. S NO. 3004.90.92.45 ANDA NO. 211769 HLBU9783370 002 THERAPEUTICE USE - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERMATITIS IN NON- HLBU9783370 002 IMMUNOCOMPROMISED ADULT AND CHILDREN 2 YEARS OF AGE TACROLIMUS OINTMENT 0.03% 30GM NDC CODE 68462088135 FDA PRODUCT CODE NO. 64 T C J 08 HLBU9783370 002 H. T. S NO. 3004.49.0050 ANDA NO. 210393 THERAPEUTICE USE TOPICAL IMMUNOSUPPRESSIVE AGENT COMMERCIAL & HLBU9783370 002 CUSTOM INVOICE NO. F22487002228 DT. 29.02.2024 SCAC CODE YASV HBL NO BOM0062163 XX CARGO DESCRIPTION XX

ASPIRIN-ER DIPYRIDAMOLECAP 25/200MG 6 PACKAGES 423 CARTONS PHARMACEUTICALS AS UNDER ASPIRIN-ER DIPYRIDAMOLE CAP 25/200MG 60 NDC CODE 68462040560 HLBU9711175 001 CODE NO 61 N C A 69 HTS NO.3004.90.9236 ANDA NO. -77-662 THERAPEUTICE USE -ANTICONVULSANT EZETIMIBE-SIMVA TAB 10/10MG 90 NDC CODE 68462032190 HLBU9711175 001 FDA PRODUCT CODE NO. 61 J D C 15 H. T. S NO. 3004.49.00.10 ANDA NO. 208699 THERAPEUTICE USE - THIS COMBINATION MEDICATION IS USED TO HELP LOWER HLBU9711175 001 BAD CHOLESTEROL AND FATS (SUCH AS LDL, TRIGLYCERIDES) AND RAISE GOOD CHOLESTEROL (HDL) IN THE BLOOD. EZETIMIBE WORKS BY REDUCING THE AMOUNT OF CHOLESTEROL YOUR BODY ABSORBS FROM HLBU9711175 001 YOUR DIET. SIMVASTATIN BELONGS TO A GROUP OF DRUGS KNOWN AS "STATINS." IT WORKS BY REDUCING THE AMOUNT OF CHOLESTEROL MADE BY THE LIVER BISOPROLOL-HCTZ TAB 5/6.25MG 30 HLBU9711175 001 NDC CODE 68462087930 FDA PRODUCT CODE NO 62 O D A 18 HTS NO.3004.49.0010 ANDA NO.215995 THERAPEUTICE USE -BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE HLBU9711175 001 TABLETS ARE INDICATED IN THE MANAGEMENT OF HYPERTENSION. GABAPENTIN TAB 600MG 500 NDC CODE 68462012605 FDA PRODUCT CODE NO 61 N C A 69 HLBU9711175 001 HTS NO.3004.90.9236 ANDA NO. -77-662 THERAPEUTICE USE -ANTICONVULSANT POTASSIUM CL ER CAP 10MEQ 100 NDC CODE 68462035701 FDA PRODUCT CODE NO. 65 R C F 14 HLBU9711175 001 H. T. S NO. 3004.90.92.90 ANDA NO. 202868 THERAPEUTICE USE - TREATMENT OR PREVENTION OF HYPOKALEMIA GABAPENTIN TAB 600MG 500 HLBU9711175 001 NDC CODE 68462012605 FDA PRODUCT CODE NO 61 N C A 69 HTS NO.3004.90.9236 ANDA NO. -77-662 THERAPEUTICE USE -ANTICONVULSANT METFORMIN HCL ER TAB HLBU9711175 001 (Z) 1000MG 90 NDC CODE 68462052190 FDA PRODUCT CODE NO. 61 P C A 55 H. T. S NO. 3004.90.92.40 ANDA NO. 212969 THERAPEUTICE USE THE HLBU9711175 001 MANAGEMENT OF TYPE 2 DIABETES XX CARGO DESCRIPTION XX HLBU9711175 002 H. T. S NO. 3004.90.92.40 ANDA NO. 212969 THERAPEUTICE USE THE MANAGEMENT OF TYPE 2 DIABETES GABAPENTIN TAB 600MG 500 NDC CODE 68462012605 HLBU9711175 002 FDA PRODUCT CODE NO 61 N C A 69 HTS NO.3004.90.9236 ANDA NO. -77-662 THERAPEUTICE USE -ANTICONVULSANT SAXAGLIPTIN TAB 5MG 90 NDC CODE 68462072790 HLBU9711175 002 FDA PRODUCT CODE NO. 61 P C A 99 H. T. S NO. 3004.90.9220 ANDA NO. 205994 THERAPEUTICE USE ANTI-DIABETIC AGENT EZETIMIBE TAB 10MG 500 HLBU9711175 002 NDC CODE 68462022605 FDA PRODUCT CODE NO. 61 J C A 15 H. T. S NO. 3004.49.00.10 ANDA NO. 078560 THERAPEUTICE USE LIPID LOWERING AGENT HLBU9711175 002 TACROLIMUS CAP 1MG 100 NDC CODE 68462068601 HTS NO 3004.90.92.15 FDA CODE 64 T C E 08 ANDA NO.206662 THERAPEUTIC USE TO PREVENT REJECTION OF A KIDNEY,HEART, OR LIVER HLBU9711175 002 TRANSPLANT SAXAGLIPTIN TAB 5MG 30 NDC CODE 68462072730 FDA PRODUCT CODE NO. 61 P C A 99 H. T. S NO. 3004.90.9220 ANDA NO. 205994 HLBU9711175 002 THERAPEUTICE USE ANTI-DIABETIC AGENT PIMECROLIMUS CREAM 1% 30GM NDC CODE 68462060935 FDA PRODUCT CODE NO. 61 S C J 04 H. T. S NO. HLBU9711175 002 3004.90.92.45 ANDA NO. 211769 THERAPEUTICE USE - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC HLBU9711175 002 DERMATITIS IN NONIMMUNOCOMPROMISED ADULT AND CHILDREN 2 YEARS OF AGE COMMERCIAL & CUSTOM INVOICE NO. F22487002201 DT. 29.02.2024 F22487002204 DT. 29.02.2024 HLBU9711175 002 F22487002212 DT. 29.02.2024 F22487002213 DT. 29.02.2024 F22487002216 DT. 29.02.2024 F22487002218 DT. 29.02.2024 F22487002220 DT. 29.02.2024 F22487002222 DT. 29.02.2024 F22487002224 DT. 29.02.2024 F22487002226 DT. 29.02.2024 HLBU9711175 002 F22487002231 DT. 29.02.2024 F22487002234 DT. 29.02.2024 F22487002235 DT. 29.02.2024 SCAC CODE YASV HBL NO BOM0062160 HLBU9711175 003 FDA PRODUCT CODE NO. 60 L D F 05 H. T. S NO. 3004.90.9220 ANDA NO. 210318 COMMERCIAL & CUSTOM INVOICE NO. F22487002202 DT. 29.02.2024 HLBU9711175 003 S/BILL NO 4003879 DT 06/03/3034 GROSS WT. 1,376.304 KGS NET WT.423.65 KGS SCAC CODE YASV HBL NO BOM0062161 06 DATA LOGGERS HUMIDITY 65%

CARVEDILOL TAB 12.5MG 500 3220 CARTONS PHARMACEUTICALS AS UNDER CARVEDILOL TAB 12.5MG 500 NDC CODE 68462016405 FDA PRODUCT CODE NO 62 O C A 22 HLBU9326116 001 HTS NO.3004.90.9221 ANDA NO.78-251 THERAPEUTICE USE -BETA- ADRENOACEPTOR ANTAGONIST BISOPROLOL-HCTZ TAB 5/6.25MG 100 HLBU9326116 001 NDC CODE 68462087901 FDA PRODUCT CODE NO 62 O D A 18 HTS NO.3004.49.0010 ANDA NO.215995 THERAPEUTICE USE -BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE HLBU9326116 001 TABLETS ARE INDICATED IN THE MANAGEMENT OF HYPERTENSION. EZETIMIBE-SIMVA TAB 10/10MG 30 NDC CODE 68462032130 FDA PRODUCT CODE NO. HLBU9326116 001 61 J D C 15 H. T. S NO. 3004.49.00.10 ANDA NO. 208699 THERAPEUTICE USE - THIS COMBINATION MEDICATION IS USED TO HELP LOWER BAD CHOLESTEROL AND HLBU9326116 001 FATS (SUCH AS LDL, TRIGLYCERIDES) AND RAISE GOOD CHOLESTEROL (HDL) IN THE BLOOD. EZETIMIBE WORKS BY REDUCING THE AMOUNT OF CHOLESTEROL YOUR BODY ABSORBS FROM YOUR DIET. SIMVASTATIN HLBU9326116 001 BELONGS TO A GROUP OF DRUGS KNOWN AS "STATINS." IT WORKS BY REDUCING THE AMOUNT OF CHOLESTEROL MADE BY THE LIVER. INDOMETHACIN ER CAP 75MG 60 NDC CODE 68462032560 FDA PRODUCT CODE 62 HLBU9326116 001 GCE42 H. T. S NO. 3004.90.92.40 ANDA NO.203501 THERAPEUTIC USE INDOMETHACIN IS USED TO RELIEVE PAIN, SWELLING, AND JOINT STIFFNESS CAUSED BY ARTHRITIS, GOUT, BURSITIS, HLBU9326116 001 AND TENDONITIS. IT IS ALSO USED TO RELIEVE PAIN FROM VARIOUS OTHER CONDITIONS. THIS MEDICATION IS KNOWN AS A NONSTEROIDAL ANTI-INFLAMMATORY DRUG (NSAID). ... HLBU9326116 001 THIS EFFECT HELPS TO DECREASE SWELLING AND PAIN. TACROLIMUS OINT 0.1% 30GM NDC CODE 68462053435 FDA PRODUCT CODE NO. 64 T C J 08 H. T. S NO. HLBU9326116 001 3004.49.00.50 ANDA NO. 210393 THERAPEUTICE USE - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERATE-TO-SEVERE HLBU9326116 001 ATOPIC DERMATITIS (ECZEMA). TACROLIMUS CAP 1MG 100 NDC CODE 68462068601 HTS NO 3004.90.92.15 FDA CODE 64 T C E 08 ANDA NO.206662 THERAPEUTIC USE TO HLBU9326116 001 PREVENT REJECTION OF A KIDNEY,HEART, OR LIVER TRANSPLANT XX CARGO DESCRIPTION XX

40 PALLETS 2197 CARTONS PH ARMACEUTICALS AS UNDER CARV EDILOL TAB 25MG 500 NDC CODE: 68462016505 FDA PRODUCT CODE NO :62 O C A 22 HTS NO.3004. 90.9221 ANDA NO.78-251 THERA PEUTICE USE:-BETA- ADRENOACE MNBU0602763 001 PTOR ANTAGONIST NICARDIPIN E HCL CAP 30MG 90 NDC CODE:68 462012190 FDA PRODUCT CODE NO .: 62 O C E 48 H. T. S NO.: 3004.90.9220 ANDA NO.: 21635 7 THERAPEUTICE USE: :#CARDIO VASCULAR AGENT (CALCIUM CHANN EL BLOCKER) EZETIMIBE-SIMV MNBU0602763 001 A TAB 10/20MG 30 NDC CODE:684 62032230 FDA PRODUCT CODE NO. : 61 J D C 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: 20869 9 THERAPEUTICE USE: :#LIPID LOWERING AGENT GABAPENTIN T AB 600MG 500 NDC CODE:6846201 2605 FDA PRODUCT CODE:NO : 6 MNBU0602763 001 1 N C A 69 HTS NO.3004.90.923 6 ANDA NO.:-77-662 THERAPEUT ICE USE:-ANTICONVULSANT PR OPAFENONE HCL ER CAP 225MG 60 NDC CODE:68462040860 FDA PRO DUCT CODE NO.: 63 E C F 28 H . T. S NO.: 3004.49.00.10 AN DA NO.:205268 THERAPEUTICE US MNBU0602763 001 E:AN ANTIARRHYTHMIC AGENT. I T IS USED TO TREAT IRREGULAR HEART RHYTHM AND CAN SLOW RA PID HEARTBEATS EZETIMIBE-S IMVA TAB 10/20MG 90 NDC CODE: 68462032290 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO. : 3004.49.00.10 ANDA NO.: 20 MNBU0602763 001 8699 THERAPEUTICE USE: :#LIP ID LOWERING AGENT RUFINAMID E TAB 400MG 120 NDC CODE:6846 2071408 61 M C A 99 3004.90. 92.30 205075 TO USED WITH OT HER MEDICATIONS TO PREVENT OR CONTROL SEIZURES (EPILEPSY) ASSOCIATED WITH LENNOX-GAST MNBU0602763 001 AUT SYNDROME (LGS BISOPROL OL-HCTZ TAB 10/6.25MG 30 NDC CODE:68462088030 FDA PRODUCT CODE NO :62 O D A 18 HTS NO. 3004.49.0010 ANDA NO.215995 THERAPEUTICE USE:-BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZ IDE TABLETS ARE INDICATED IN MNBU0602763 001 THE MANAGEMENT OF HYPERTENS ION. FENOFIBRATE CAP 67MG 1 00 NDC CODE:68462058001 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.20 A NDA NO.: 205566 THERAPEUTICE USE: - INDICATED AS ADJUNCTIV E THERAPY TO DIET FOR THE RE MNBU0602763 001 DUCTION OF LDL-C, TOTAL-C, TR IGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMARY HYPER CHOLESTEROLEMIA OR MIXED DYSL IPIDEMIA CARVEDILOL TAB 25M G 500 NDC CODE:68462016505 F DA PRODUCT CODE NO :62 O C A 22 HTS NO.3004.90.9221 ANDA MNBU0602763 001 NO.78-251 THERAPEUTICE USE:- BETA- ADRENOACEPTOR ANTAGONI ST TACROLIMUS OINT 0.1% 100 GM NDC CODE:68462053494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTIC E USE: - TACROLIMUS IS A TOPI MNBU0602763 001 CAL IMMUNOSUPPRESSIVE OINTME NT USED FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DE RMATITIS (ECZEMA). TACROLI MUS OINT 0.1% 30GM NDC CODE:6 8462053435 FDA PRODUCT CODE N O.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210 MNBU0602763 001 393 THERAPEUTICE USE: - TACR OLIMUS IS A TOPICAL IMMUNOSUP PRESSIVE OINTMENT USED FOR TH E TREATMENT OF MODERATE-TO-S EVERE ATOPIC DERMATITIS (ECZ EMA). PIMECROLIMUS CREAM 1% 30GM NDC CODE:68462060935 F DA PRODUCT CODE NO.: 61 S C J MNBU0602763 001 04 H. T. S NO.: 3004.90.92. 45 ANDA NO.: 211769 THERAPEU TICE USE: - AS SECOUND-LINE T HERAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC TRERT MENT OF MILD TO MODERATE ATOP IC DERMATITIS IN NONIMMUNOCO MPROMISED ADULT AND CHILDREN MNBU0602763 001 2 YEARS OF AGE TACROLIMUS OINTMENT 0.03% 100GM NDC CODE :68462088194 FDA PRODUCT CODE NO.:64 T C J 08 H. T. S NO. : 3004.49.0050 ANDA NO.:2103 93 THERAPEUTICE USE: TOPICAL IMMUNOSUPPRESSIVE AGENT COMMERCIAL & CUSTOM INVOICE NO MNBU0602763 001 . F22487001926 DT. 22.01.2024 F22487001922 DT. 20.01.2024 F22487001921 DT. 20.01.2024 F22487001920 DT. 20.01.2024 F 22487001919 DT. 20.01.2024 F2 2487001917 DT. 20.01.2024 S/B ILL NO: 4001056 DT: 22/01/2024 S/BILL NO: 4001055 DT: 22/01 MNBU0602763 001 /2024 S/BILL NO: 4001053 DT: 22/01/2024 S/BILL NO: 4001054 DT: 22/01/2024 S/BILL NO: 40 01052 DT: 22/01/2024 S/BILL N O: 4001051 DT: 22/01/2024 NET WT. 5823.454 KGS 02 DATA LO GGERS HUMIDITY:65% SET TEMPE RATURE : +20 DEGREES TEMPERAT MNBU0602763 001 URE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH-07430 USA

37 PALLETS 2335 CARTONS PH ARMACEUTICALS AS UNDER POTA SSIUM CL ER CAP 10MEQ 100 NDC CODE:68462035701 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO .:202868 THERAPEUTICE USE: - MNBU0437740 001 TREATMENT OR PREVENTION OF HYPOKALEMIA RUFINAMIDE TAB 400MG 120 NDC CODE:6846207140 8 61 M C A 99 3004.90.92.30 205075 TO USED WITH OTHER M EDICATIONS TO PREVENT OR CONT ROL SEIZURES (EPILEPSY) ASSO CIATED WITH LENNOX-GASTAUT S MNBU0437740 001 YNDROME (LGS SAXAGLIPTIN TA B 5MG 30 NDC CODE:68462072730 FDA PRODUCT CODE NO.:61 P C A 99 H. T. S NO.: 3004.90.9 220 ANDA NO.:205994 THERAPEU TICE USE: :#ANTI-DIABETIC AGE NT INDOMETHACIN ER CAP 75MG 60 NDC CODE:68462032560 FDA MNBU0437740 001 PRODUCT CODE: 62 GCE42 H. T . S NO.:3004.90.92.40 ANDA N O.203501 THERAPEUTIC USE: IN DOMETHACIN IS USED TO RELIEVE PAIN, SWELLING, AND JOINT ST IFFNESS CAUSED BY ARTHRITIS, GOUT, BURSITIS, AND TENDONITI S. IT IS ALSO USED TO RELIEVE MNBU0437740 001 PAIN FROM VARIOUS OTHER CON DITIONS. THIS MEDICATION IS K NOWN AS A NONSTEROIDAL ANTI- INFLAMMATORY DRUG (NSAID). .. . THIS EFFECT HELPS TO DECRE ASE SWELLING AND PAIN. FEN OFIBRATE CAP 200MG 100 NDC CO DE:68462058201 FDA PRODUCT CO MNBU0437740 001 DE NO.: 61 JCE 09 H. T. S NO .: 3004.90.92.20 ANDA NO.: 2 05566 THERAPEUTICE USE: - IN DICATED AS ADJUNCTIVE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, TOTAL-C, TRIGLYCERIDE S AND APO B IN DULT PATIENTS WITH PRMARY HYPERCHOLESTERO MNBU0437740 001 LEMIA OR MIXED DYSLIPIDEMIA FENOFIBRATE CAP 134MG 100 N DC CODE:68462058101 FDA PRODU CT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.20 ANDA N O.: 205566 THERAPEUTICE USE: - INDICATED AS ADJUNCTIVE TH ERAPY TO DIET FOR THE REDUCTI MNBU0437740 001 ON OF LDL-C, TOTAL-C, TRIGLYC ERIDES AND APO B IN DULT PAT IENTS WITH PRMARY HYPERCHOLE STEROLEMIA OR MIXED DYSLIPIDE MIA NAPROXEN SOD TAB 275MG 100 NDC CODE:68462017801 FDA PRODUCT CODE NO.:-62 G C A 5 0 H. T. S NO.: 3004.90.92.40 MNBU0437740 001 ANDA NO.:-78-314 THERAPEUTI CE USE:-ANTI -INFLAMMATORY, A NALGESIC TACROLIMUS OINT 0. 1% 100GM NDC CODE:68462053494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49. 00.50 ANDA NO.: 210393 THERA PEUTICE USE: - TACROLIMUS IS MNBU0437740 001 A TOPICAL IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATME NT OF MODERATE-TO-SEVERE ATO PIC DERMATITIS (ECZEMA). T ACROLIMUS OINT 0.1% 60GM NDC CODE:68462053465 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO MNBU0437740 001 .: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMM UNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERAT E-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). TACROLIMUS CAP 0.5MG 100 NDC CODE:6846206850 1 FDA PRODUCT CODE NO.: 64 T MNBU0437740 001 C E 08 H. T. S NO.:3004.90. 92.15 ANDA NO.: 206662 THERA PEUTICE USE: :#TO PREVENT REJ ECTION OF A KIDNEY,TO PREVENT REJECTION OF A KIDNEY,LIVER TRANSPLANT TACROLIMUS CAP 1MG 100 NDC CODE:68462068601 HTS NO: 3004.90.92.15 FDA CO MNBU0437740 001 DE : 64 T C E 08 ANDA NO.2066 62 THERAPEUTIC USE : TO PREV ENT REJECTION OF A KIDNEY,HEA RT, OR LIVER TRANSPLANT CO MMERCIAL & CUSTOM INVOICE NO. F22487001748 DT. 30.12.2023 F22487001749 DT. 30.12.2023 S /BILL NO: 4020294 DT:30/12/202 MNBU0437740 001 3 S/BILL NO: 4020292 DT:30/12 /2023 NET WT. 3110.165 KGS 02 DATA LOGGERS SET TEMPE RATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTI CALS INC 750, CORPORATE DRIVE , NEW JERSEY MAHWAH - 07430 USA

30 PALLETS 1943 CARTONS P HARMACEUTICALS AS UNDER TAC ROLIMUS OINT 0.1% 60GM NDC CO DE:68462053465 FDA PRODUCT CO DE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE: - MNBU4110226 001 TACROLIMUS IS A TOPICAL IMMUN OSUPPRESSIVE OINTMENT USED FO R THE TREATMENT OF MODERATE- TO-SEVERE ATOPIC DERMATITIS (ECZEMA). EZETIMIBE-SIMVA T AB 10/20MG 30 NDC CODE:684620 32230 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO.: 300 MNBU4110226 001 4.49.00.10 ANDA NO.: 208699 THERAPEUTICE USE: :#LIPID LOW ERING AGENT CLINDAMYCIN HCL CAP 150MG 500 NDC CODE:68462 014305 FDA PRODUCT CODE NO.: 56 J C E 20 H. T. S NO.: 294 1.90.5000 ANDA NO.:216957 TH ERAPEUTICE USE: :#TREATMENT O MNBU4110226 001 F NUMEROUS INFECTIONS, INCLUD ING BUT NOT LIMITED TO SEPT ICEMIA,INTRAABDOMINAL INFECTI ONS, LOWER RESPIRATORY INFEC TIONS, GYNECOLOGICAL INFECTIO NS, BONE AND JOINT INFECTIONS , AND SKIN AND SKIN STRUCTURE INFECTIONS RUFINAMIDE TAB MNBU4110226 001 400MG 120 NDC CODE:684620714 08 61 M C A 99 3004.90.92.30 205075 TO USED WITH OTHER MEDICATIONS TO PREVENT OR CON TROL SEIZURES (EPILEPSY) ASS OCIATED WITH LENNOX-GASTAUT SYNDROME (LGS CLINDAMYCIN H CL CAP 150MG 500 NDC CODE:684 MNBU4110226 001 62014305 FDA PRODUCT CODE NO .:56 J C E 20 H. T. S NO.: 2 941.90.5000 ANDA NO.:216957 THERAPEUTICE USE: :#TREATMENT OF NUMEROUS INFECTIONS, INCL UDING BUT NOT LIMITED TO SE PTICEMIA,INTRAABDOMINAL INFEC TIONS, LOWER RESPIRATORY INF MNBU4110226 001 ECTIONS, GYNECOLOGICAL INFECT IONS, BONE AND JOINT INFECTIO NS, AND SKIN AND SKIN STRUCTU RE INFECTIONS TACROLIMUS C AP 1MG 100 NDC CODE:684620686 01 HTS NO: 3004.90.92.15 FDA CODE : 64 T C E 08 ANDA NO.2 06662 THERAPEUTIC USE : TO P MNBU4110226 001 REVENT REJECTION OF A KIDNEY, HEART, OR LIVER TRANSPLANT BISOPROLOL-HCTZ TAB 5/6.25MG 100 NDC CODE:68462087901 FDA PRODUCT CODE NO.: 62 O D A 1 8 H. T. S NO.: 3004.40.00.20 ANDA NO.: 215995 THERAPEUTI CE USE: BISOPROLOL FUMARATE A MNBU4110226 001 ND HYDROCHLOROTHIAZIDE TABLE TS ARE INDICATED IN THE MANA GEMENT OF HYPERTENSION. BI SOPROLOL-HCTZ TAB 10/6.25MG 50 0 NDC CODE:68462088005 FDA P RODUCT CODE NO.: 62 O D A 18 H. T. S NO.: 3004.40.00.20 ANDA NO.: 215995 THERAPEUTICE MNBU4110226 001 USE: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE TABLETS ARE INDICATED IN THE MANAGE MENT OF HYPERTENSION. SOLI FENACIN SUCCINATE TAB 10MG 30 NDC CODE:68462038730 FDA PRO DUCT CODE NO.: 61 KCA 72 H. T. S NO.: 3004 49 00 70 ANDA MNBU4110226 001 NO.: 209239 INDICATED FOR TH E TREATMENT OF OVERACTIVE BL ADDER WITH SYMPTOMS OF URGE U RINARY INCONTINENCE, URGENCY AND URINARY FREQUENCY SOLI FENACIN SUCCINATE TAB 10MG 90 NDC CODE:68462038790 FDA PRO DUCT CODE NO.: 61 KCA 72 H. MNBU4110226 001 T. S NO.: 3004 49 00 70 ANDA NO.: 209239 INDICATED FOR TH E TREATMENT OF OVERACTIVE BL ADDER WITH SYMPTOMS OF URGE U RINARY INCONTINENCE, URGENCY AND URINARY FREQUENCY COMM ERCIAL & CUSTOM INVOICE NO. F 22487001778 DT. 31.12.2023 F2 MNBU4110226 001 2487001779 DT. 31.12.2023 F22 487001780 DT. 31.12.2023 F224 87001789 DT. 31.12.2023 F2248 7001797 DT. 31.12.2023 F22487 001823 DT. 04.01.2024 F224870 01824 DT. 04.01.2024 S/BILL N O: 4000147 DT: 04/01/2024 S/B ILL NO: 4000145 DT: 04/01/2024 MNBU4110226 001 S/BILL NO: 4000137 DT: 04/01 /2024 S/BILL NO: 4000142 DT: 04/01/2024 S/BILL NO: 4000144 DT: 04/01/2024 S/BILL NO: 40 00149 DT: 04/01/2024 S/BILL N O: 4000148 DT: 04/01/2024 NET WT. 1732.873 KGS HUMIDITY:6 5% SET TEMPERATURE : +20 DEGR MNBU4110226 001 EES TEMPERATURE RANGE : +15 D EGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTIC ALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA NOTIFY PARTY:3 GLENMARK SPECIALTY S.A. SWITZERLAND (G SSA) PLACE DU PORT 2 NEUCHAT MNBU4110226 001 EL - 2000 SWITZERLAND

26 PALLETS 1305 CARTONS PH ARMACEUTICALS AS UNDER TACR OLIMUS OINT 0.1% 100GM NDC CO DE:68462053494 FDA PRODUCT CO DE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE: - MNBU0632876 001 TACROLIMUS IS A TOPICAL IMMUN OSUPPRESSIVE OINTMENT USED FO R THE TREATMENT OF MODERATE- TO-SEVERE ATOPIC DERMATITIS (ECZEMA). TACROLIMUS OINT 0 .1% 30GM NDC CODE:68462053435 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49. MNBU0632876 001 00.50 ANDA NO.: 210393 THERA PEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATME NT OF MODERATE-TO-SEVERE ATO PIC DERMATITIS (ECZEMA). T ACROLIMUS OINT 0.1% 60GM NDC CODE:68462053465 FDA PRODUCT MNBU0632876 001 CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO .: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMM UNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERAT E-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). PIMECROLIMUS CR MNBU0632876 001 EAM 1% 30GM NDC CODE:68462060 935 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004. 90.92.45 ANDA NO.: 211769 TH ERAPEUTICE USE: - AS SECOUND- LINE THERAPY FOR THE SHORT-TE RM AND NON-CONTINUOS CHRONIC TRERTMENT OF MILD TO MODERAT MNBU0632876 001 E ATOPIC DERMATITIS IN NONIM MUNOCOMPROMISED ADULT AND CHI LDREN 2 YEARS OF AGE POTAS SIUM CL ER CAP 10MEQ 100 NDC CODE:68462035701 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO. :202868 THERAPEUTICE USE: - MNBU0632876 001 TREATMENT OR PREVENTION OF H YPOKALEMIA GABAPENTIN TAB 6 00MG 500 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.9 2.30 ANDA NO.:-77-662 THERAP EUTICE USE:-ANTICONVULSANT A GENT COMMERCIAL & CUSTOM IN MNBU0632876 001 VOICE NO. F22487001678 DT. 20 .12.2023 F22487001679 DT. 20. 12.2023 F22487001682 DT. 20.1 2.2023 S/BILL NO: 4019640 DT: 21/12/2023 S/BILL NO: 4019641 DT:21/12/2023 S/BILL NO: 401 9645 DT:21/12/2023 NET WT. 42 93.181 KGS 02 DATA LOGGERS MNBU0632876 001 SET TEMPERATURE : +20 DEGRE ES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, COR PORATE DRIVE, NEW JERSEY MAH WAH - 07430 USA

34 PALLETS 2008 CARTONS P HARMACEUTICALS AS UNDER EZE TIMIBE TAB 10MG 30 NDC CODE:6 8462022630 FDA PRODUCT CODE N O.: 61 J C A 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: #07 8560 THERAPEUTICE USE: LIPID TLLU1163267 001 LOWERING AGENT EZETIMIBE-S IMVA TAB 10/40MG 30 NDC CODE: 68462032330 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO. : 3004.49.00.10 ANDA NO.: 20 8699 THERAPEUTICE USE: - THIS COMBINATION MEDICATION IS U SED TO HELP LOWER BAD CHOLEST TLLU1163267 001 EROL AND FATS (SUCH AS LDL, TRIGLYCERIDES) AND RAISE GOOD CHOLESTEROL (HDL) IN THE BLO OD. EZETIMIBE WORKS BY REDUCI NG THE AMOUNT OF CHOLESTEROL YOUR BODY ABSORBS FROM YOUR DIET. SIMVASTATIN BELONGS TO A GROUP OF DRUGS KNOWN AS "ST TLLU1163267 001 ATINS." IT WORKS BY REDUCING THE AMOUNT OF CHOLESTEROL MA DE BY THE LIVER. METFORMIN HCL ER TAB (Z) 1000MG 90 NDC CODE:68462052190 FDA PRODUCT CODE NO.: 61 P C A 55 H. T. S NO.: 3004.90.92.40 ANDA NO .:212969 THERAPEUTICE USE: TH TLLU1163267 001 E MANAGEMENT OF TYPE 2 DIABE TES DILTIAZEM HCL ER CAP 12 HR 60MG 100 NDC CODE:68462085 001 62 O C B 24 3004.49.00.1 0 212317 FOR THE TREATMENT O F HYPERTENSION. CARVEDIL OL TAB 12.5MG 500 NDC CODE:68 462016405 FDA PRODUCT CODE NO TLLU1163267 001 : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78- 251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST EZETIMIBE TAB 10MG 90 NDC COD E:68462022690 FDA PRODUCT COD E NO.: 61 J C A 15 H. T. S N O.: 3004.49.00.10 ANDA NO.: TLLU1163267 001 #078560 THERAPEUTICE USE: LIP ID LOWERING AGENT TACROLIM US OINT 0.1% 60GM NDC CODE:68 462053465 FDA PRODUCT CODE NO .: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 2103 93 THERAPEUTICE USE: - TACRO LIMUS IS A TOPICAL IMMUNOSUPP TLLU1163267 001 RESSIVE OINTMENT USED FOR THE TREATMENT OF MODERATE-TO-SE VERE ATOPIC DERMATITIS (ECZE MA). SIROLIMUS TAB 2MG 100 NDC CODE:68462068401 FDA PRO DUCT CODE NO.: 64 T C A 12 H . T. S NO.: 3004.90.92.15 AN DA NO.: 208691 THERAPEUTICE U TLLU1163267 001 SE: TO PREVENT REJECTION OF KIDNEY TRANSPLANTS. POTASSI UM CL ER CAP 10MEQ 100 NDC CO DE:68462035701 FDA PRODUCT CO DE NO.:65 R C F 14 H. T. S N O.: 3004.90.92.90 ANDA NO.:2 02868 THERAPEUTICE USE: - TR EATMENT OR PREVENTION OF HYPO TLLU1163267 001 KALEMIA POTASSIUM CL ER CAP 10MEQ 100 NDC CODE:684620357 01 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90 .92.90 ANDA NO.:202868 THERA PEUTICE USE: - TREATMENT OR P REVENTION OF HYPOKALEMIA COMMERCIAL & CUSTOM INVOICE NO TLLU1163267 001 . F22487001464 DT. 21.11.2023 F22487001466 DT. 21.11.2023 F22487001467 DT. 21.11.2023 F22487001469 DT. 21.11.2023 F 22487001472 DT. 22.11.2023 S/ BILL NO: 4017836 DT: 22/11/202 3 S/BILL NO: 4017835 DT: 22/1 1/2023 S/BILL NO: 4017834 DT: TLLU1163267 001 22/11/2023 S/BILL NO: 401783 3 DT: 22/11/2023 S/BILL NO: 4 017832 DT: 22/11/2023 NET WT. 2903.005 KGS 02 DATA LOGGER S HUMIDITY:65% SET TEMPERATU RE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEG REES NOTIFY PARTY:2 GLENMARK TLLU1163267 001 PHARMACEUTICALS INC 750, COR PORATE DRIVE, NEW JERSEY MAH WAH - 07430 USA

30 PALLETS 2353 CARTONS PH ARMACEUTICALS AS UNDER EZET IMIBE TAB 10MG 90 NDC CODE:68 462022690 FDA PRODUCT CODE NO .: 61 J C A 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: #078 560 THERAPEUTICE USE: LIPID MNBU0655866 001 LOWERING AGENT CARVEDILOL T AB 25MG 500 NDC CODE:68462016 505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004. 90.92.20 ANDA NO.:- 78-251 T HERAPEUTICE USE:-BETA- ADREN OACEPTOR ANTAGONIST TACROL IMUS OINT 0.1% 60GM NDC CODE: MNBU0655866 001 68462053465 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO. : 3004.49.00.50 ANDA NO.: 21 0393 THERAPEUTICE USE: - TAC ROLIMUS IS A TOPICAL IMMUNOSU PPRESSIVE OINTMENT USED FOR T HE TREATMENT OF MODERATE-TO- SEVERE ATOPIC DERMATITIS (EC MNBU0655866 001 ZEMA). TACROLIMUS CAP 0.5MG 100 NDC CODE:68462068501 FD A PRODUCT CODE NO.: 64 T C E 08 H. T. S NO.:3004.90.92.15 ANDA NO.: 206662 THERAPEUTI CE USE: :#TO PREVENT REJECTIO N OF A KIDNEY,TO PREVENT REJ ECTION OF A KIDNEY,LIVER TRAN MNBU0655866 001 SPLANT EZETIMIBE TAB 10MG 9 0 NDC CODE:68462022690 FDA P RODUCT CODE NO.: 61 J C A 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: #078560 THERAPEUTIC E USE: LIPID LOWERING AGENT POTASSIUM CL ER CAP 10MEQ 50 0 NDC CODE:68462035705 FDA P MNBU0655866 001 RODUCT CODE NO.: 65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO.: 202868 THERAPEUTICE USE: - TREATMENT OR PREVENTI ON OF HYPOKALEMIA TACROLIM US OINT 0.1% 100GM NDC CODE:6 8462053494 FDA PRODUCT CODE N O.: 64 T C J 08 H. T. S NO.: MNBU0655866 001 3004.49.00.50 ANDA NO.: 210 393 THERAPEUTICE USE: - TACR OLIMUS IS A TOPICAL IMMUNOSUP PRESSIVE OINTMENT USED FOR TH E TREATMENT OF MODERATE-TO-S EVERE ATOPIC DERMATITIS (ECZ EMA). COMMERCIAL & CUSTOM I NVOICE NO. F22487001353 DT. 3 MNBU0655866 001 1.10.2023 F22487001365 DT. 31 .10.2023 F22487001366 DT. 31. 10.2023 F22487001367 DT. 31.1 0.2023 F22487001373 DT. 31.10 .2023 F22487001370 DT. 31.10. 2023 S/BILL NO: 4017023 DT:02 .11.2023 S/BILL NO: 4017016 D T:02.11.2023 S/BILL NO: 40170 MNBU0655866 001 17 DT:02.11.2023 S/BILL NO: 4 017018 DT:02.11.2023 S/BILL N O: 4017021 DT:02.11.2023 S/BI LL NO: 4017020 DT:02.11.2023 NET WT. 3914.378 KGS 02 DAT A LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC MNBU0655866 001 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH - 07430 USA

11 PALLETS 729 CARTONS PHA RMACEUTICALS AS UNDER TACRO LIMUS CAP 1MG 100 NDC CODE:68 462068601 HTS NO: 3004.90.92. 15 FDA CODE : 64 T C E 08 AN DA NO.206662 THERAPEUTIC USE : TO PREVENT REJECTION OF A MMAU1256856 001 KIDNEY,HEART, OR LIVER TRANSP LANT TACROLIMUS OINT 0.1% 6 0GM NDC CODE:68462053465 FDA PRODUCT CODE NO.: 64 T C J 0 8 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTI CE USE: - TACROLIMUS IS A TOP ICAL IMMUNOSUPPRESSIVE OINTM MMAU1256856 001 ENT USED FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC D ERMATITIS (ECZEMA). TACROL IMUS OINTMENT 0.03% 30GM NDC CODE:68462088135 FDA PRODUCT CODE NO.:64 T C J 08 H. T. S NO.: 3004.49.0050 ANDA NO.: 210393 THERAPEUTICE USE: TOP MMAU1256856 001 ICAL IMMUNOSUPPRESSIVE AGENT COMMERCIAL & CUSTOM INVOIC E NO. F22487001361 DT. 31.10. 2023 S/BILL NO: 4016959 DT: 0 1.11.2023 NET WT. 871.384 KGS 04 DATA LOGGERS SET TEMPE RATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTI MMAU1256856 001 CALS INC 750, CORPORATE DRIVE , NEW JERSEY MAHWAH - 07430 USA

29 PALLETS 2278 CARTONS PH ARMACEUTICALS AS UNDER POTA SSIUM CL ER CAP 10MEQ 500 NDC CODE:68462035705 FDA PRODUCT CODE NO.: 65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA N O.: 202868 THERAPEUTICE USE: MNBU0146046 001 - TREATMENT OR PREVENTION OF HYPOKALEMIA FENOFIBRATE CA P 67MG 100 NDC CODE:684620580 01 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90. 92.20 ANDA NO.: 205566 THERA PEUTICE USE: - INDICATED AS A DJUNCTIVE THERAPY TO DIET FOR MNBU0146046 001 THE REDUCTION OF LDL-C, TOT AL-C, TRIGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMAR Y HYPERCHOLESTEROLEMIA OR MI XED DYSLIPIDEMIA FENOFIBRAT E CAP 134MG 100 NDC CODE:6846 2058101 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 300 MNBU0146046 001 4.90.92.20 ANDA NO.: 205566 THERAPEUTICE USE: - INDICATED AS ADJUNCTIVE THERAPY TO DIE T FOR THE REDUCTION OF LDL-C, TOTAL-C, TRIGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMARY HYPERCHOLESTEROLEMIA O R MIXED DYSLIPIDEMIA TACRO MNBU0146046 001 LIMUS CAP 1MG 100 NDC CODE:68 462068601 HTS NO: 3004.90.92. 15 FDA CODE : 64 T C E 08 AN DA NO.206662 THERAPEUTIC USE : TO PREVENT REJECTION OF A KIDNEY,HEART, OR LIVER TRANSP LANT TACROLIMUS OINT 0.1% 3 0GM NDC CODE:68462053435 FDA MNBU0146046 001 PRODUCT CODE NO.: 64 T C J 0 8 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTI CE USE: - TACROLIMUS IS A TOP ICAL IMMUNOSUPPRESSIVE OINTM ENT USED FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC D ERMATITIS (ECZEMA). GABAPE MNBU0146046 001 NTIN TAB 600MG 500 NDC CODE:6 8462012605 FDA PRODUCT CODE N O: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-6 62 THERAPEUTICE USE:-ANTICON VULSANT AGENT COMMERCIAL & CUSTOM INVOICE NO. F22487001 279 DT. 19.10.2023 F224870012 MNBU0146046 001 81 DT. 19.10.2023 F2248700128 6 DT. 19.10.2023 S/BILL NO: 4 016169 DT: 19.10.2023 S/BILL NO: 4016171 DT: 19.10.2023 S/ BILL NO: 4016172 DT: 19.10.202 3 NET WT. 3467.777 KGS 02 D ATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TE MNBU0146046 001 MPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH - 07430 USA

27 PALLETS 1356 CARTONS PH ARMACEUTICALS AS UNDER TACR OLIMUS CAP 1MG 100 NDC CODE:6 8462068601 HTS NO: 3004.90.92 .15 FDA CODE : 64 T C E 08 A NDA NO.206662 THERAPEUTIC USE : TO PREVENT REJECTION OF A SUDU8246664 001 KIDNEY,HEART, OR LIVER TRANS PLANT TACROLIMUS OINT 0.1% 60GM NDC CODE:68462053465 FD A PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.5 0 ANDA NO.: 210393 THERAPEUT ICE USE: - TACROLIMUS IS A TO PICAL IMMUNOSUPPRESSIVE OINT SUDU8246664 001 MENT USED FOR THE TREATMENT O F MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). CLIND AMYCIN HCL CAP 75MG 100 NDC C ODE:68462014201 PRAVASTATIN SOD TAB 80MG 90 NDC CODE:684 62019890 FDA PRODUCT CODE NO .:-61 J C A 13 H. T. S NO.: SUDU8246664 001 3004.90.92.20 ANDA NO.:-77-98 7 THERAPEUTICE USE:-HYPOLIPD AEMIC FENOFIBRATE CAP 67MG 100 NDC CODE:68462058001 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.20 ANDA NO.: 205566 THERAPEUTICE USE: - INDICATED AS ADJUNCTI SUDU8246664 001 VE THERAPY TO DIET FOR THE R EDUCTION OF LDL-C, TOTAL-C, T RIGLYCERIDES AND APO B IN DUL T PATIENTS WITH PRMARY HYPE RCHOLESTEROLEMIA OR MIXED DYS LIPIDEMIA CLINDAMYCIN HCL C AP 300MG 100 NDC CODE:6846201 4401 FDA PRODUCT CODE NO.:56 SUDU8246664 001 J C E 20 H. T. S NO.: 2941. 90.5000 ANDA NO.:216957 THER APEUTICE USE: :#TREATMENT OF NUMEROUS INFECTIONS, INCLUDIN G BUT NOT LIMITED TO SEPTIC EMIA,INTRAABDOMINAL INFECTION S, LOWER RESPIRATORY INFECTI ONS, GYNECOLOGICAL INFECTIONS SUDU8246664 001 , BONE AND JOINT INFECTIONS, AND SKIN AND SKIN STRUCTURE INFECTIONS COMMERCIAL & CUS TOM INVOICE NO. F22487001233 DT. 10.10.2023 F22487001234 D T. 10.10.2023 F22487001235 DT . 10.10.2023 S/BILL NO: 40156 89 DT: 11.10.2023 S/BILL NO: SUDU8246664 001 4015692 DT: 11.10.2023 S/BILL NO: 4015690 DT: 11.10.2023 N ET WT. 2560.638 KGS 02 DATA L OGGERS SET TEMPERATURE : +1 8 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA

42 PALLETS 2985 CARTONS P HARMACEUTICALS AS UNDER POT ASSIUM CL ER CAP 10MEQ 100 N DC CODE:68462035701 FDA PRODU CT CODE NO.:65 R C F 14 H. T . S NO.: 3004.90.92.90 ANDA NO.:202868 THERAPEUTICE USE: MNBU0418864 001 - TREATMENT OR PREVENTION OF HYPOKALEMIA PROCHLORPERAZ INE MAL TAB 5MG 100 NDC CODE: 68462088901 POTASSIUM CL ER CAP 10MEQ 500 NDC CODE:68462 035705 FDA PRODUCT CODE NO.: 65 R C F 14 H. T. S NO.: 30 04.90.92.90 ANDA NO.: 202868 MNBU0418864 001 THERAPEUTICE USE: - TREATMEN T OR PREVENTION OF HYPOKALEMI A TACROLIMUS OINT 0.1% 30GM NDC CODE:68462053435 FDA PR ODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 A NDA NO.: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICA MNBU0418864 001 L IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF M ODERATE-TO-SEVERE ATOPIC DERM ATITIS (ECZEMA). TACROLIMU S CAP 1MG 100 NDC CODE:684620 68601 HTS NO: 3004.90.92.15 FDA CODE : 64 T C E 08 ANDA N O.206662 THERAPEUTIC USE : TO MNBU0418864 001 PREVENT REJECTION OF A KIDN EY,HEART, OR LIVER TRANSPLANT GABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FDA PROD UCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-662 THERAPEUTICE US E:-ANTICONVULSANT AGENT CL MNBU0418864 001 INDAMYCIN HCL CAP 75MG 100 ND C CODE:68462014201 PRAVASTA TIN SOD TAB 80MG 90 NDC CODE: 68462019890 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO. : 3004.90.92.20 ANDA NO.:-77 -987 THERAPEUTICE USE:-HYPOL IPDAEMIC COMMERCIAL & CUSTO MNBU0418864 001 M INVOICE NO. F22487001158 DT . 30.09.2023 F22487001169 DT. 30.09.2023 F22487001196 DT. 30.09.2023 F22487001211 DT. 0 5.10.2023 F22487001212 DT. 05 .10.2023 S/BILL NO: 4015476 DT: 06.10.2023 S/BILL NO: 401 5475 DT: 06.10.2023 S/BILL N MNBU0418864 001 O: 4015474 DT: 06.10.2023 S/ BILL NO: 4015473 DT: 06.10.20 23 S/BILL NO: 4015469 DT: 06 .10.2023 NET WT. 5518.521 KGS 02 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE DRI MNBU0418864 001 VE, NEW JERSEY MAHWAH - 0743 0 USA

43 PALLETS 2319 CARTONS PH ARMACEUTICALS AS UNDER GABA PENTIN TAB 600MG 500 NDC CODE :68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO. : 3004.90.92.30 ANDA NO.:-77 -662 THERAPEUTICE USE:-ANTIC MNBU0239597 001 ONVULSANT AGENT NITROGLYCE RIN SUBLING TAB 0.4MG 4X25 ND C CODE:68462063945 FDA PRODUC T CODE NO.: 66 S C A 28 H. T . S NO.: 3004.90.9020 ANDA N O.:206391 THERAPEUTIC USE: - MEDICATION USED FOR HEART FAI LURE,HIGH BLOOD PRESSURE,AND MNBU0239597 001 TO TREAT AND PREVENT CHEST PA IN FROM NOT ENOUGH BLOOD FLOW TO THE HEART NAPROXEN SOD TAB 550MG 100 NDC CODE:68462 017901 FDA PRODUCT CODE NO.: -62 G C A 50 H. T. S NO.: 30 04.90.92.40 ANDA NO.:-78-314 THERAPEUTICE USE:-ANTI -INFL MNBU0239597 001 AMMATORY, ANALGESIC APREPIT ANT CAP 125MG 6UD NDC CODE:68 462058576 NDC NO.:68462058576 FDA PRODUCT CODE NO.: 61 T C E 32 H. T. S NO.: 3004.90. 92.40 ANDA NO.:207777 THERAP EUTICE USE:APREPITANT IS USED WITH OTHER MEDICATIONS TO H MNBU0239597 001 ELP PREVENT NAUSEA AND VOMITI NG CAUSED BY CANCER DRUG TREA TMENT (CHEMOTHERAPY). THIS M EDICATION IS ALSO USED TO PRE VENT NAUSEA AND VOMITING AFTE R SURGERY. A-EMETIC/NAUSEANT / HUMAN - RX/SINGLE INGREDIE NT / DELAYED RELEASE TABLETS MNBU0239597 001 / APREPITANT NITROGLYCERIN SUBLING TAB 0.4MG 4X25 NDC C ODE:68462063945 FDA PRODUCT C ODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.: 206391 THERAPEUTIC USE: -MED ICATION USED FOR HEART FAILUR E,HIGH BLOOD PRESSURE,AND TO MNBU0239597 001 TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART TACROLIMUS CAP 1MG 100 NDC CODE:68462068601 HTS NO: 3004.90.92.15 FDA CO DE : 64 T C E 08 ANDA NO.2066 62 THERAPEUTIC USE : TO PREV ENT REJECTION OF A KIDNEY,HEA MNBU0239597 001 RT, OR LIVER TRANSPLANT TA CROLIMUS OINT 0.1% 60GM NDC C ODE:68462053465 FDA PRODUCT C ODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO. : 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMU NOSUPPRESSIVE OINTMENT USED F MNBU0239597 001 OR THE TREATMENT OF MODERATE -TO-SEVERE ATOPIC DERMATITIS (ECZEMA). GABAPENTIN TAB 6 00MG 500 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.9 2.30 ANDA NO.:-77-662 THERAP EUTICE USE:-ANTICONVULSANT A MNBU0239597 001 GENT DILTIAZEM HCL ER CAP 1 2HR 120MG 100 NDC CODE:684620 56201 62 O C B 24 3004.49.00 .10 212317 FOR THE TREATMENT OF HYPERTENSION. PROPAFEN ONE HCL ER CAP 325MG 60 NDC C ODE:68462040960 FDA PRODUCT C ODE NO.: 63 E C F 28 H. T. S MNBU0239597 001 NO.: 3004.49.00.10 ANDA NO. : 205268 THERAPEUTICE USE: -A N ANTIARRHYTHMIC AGENT IT IS USED TO TREAT IRREGULAR HEAR TRHYTHM AND CAN SLOW RAPID HE ARTBEATS TOPIRAMATE ER CAP (Q) 50MG 30 NDC CODE:68462037 330 3004.49.00.20 61 M C B 4 MNBU0239597 001 0 210278 GABAPENTIN TAB 60 0MG 500 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92 .30 ANDA NO.:-77-662 THERAPE UTICE USE:-ANTICONVULSANT AG ENT TOPIRAMATE ER CAP (Q) 2 5MG 30 NDC CODE:68462037230 MNBU0239597 001 3004.49.00.20 61 M C B 40 21 0278 GABAPENTIN TAB 600MG 5 00 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT AGENT GABAPENTIN TAB 600MG 500 ND MNBU0239597 001 C CODE:68462012605 FDA PRODUC T CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA N O.:-77-662 THERAPEUTICE USE: -ANTICONVULSANT AGENT COLE SEVELAM HCL TAB 625MG 180 NDC CODE:68462043318 FDA PRODUCT CODE NO.: 62 B D A 13 H. T. MNBU0239597 001 S NO.: 3004.49.00.10 ANDA N O.: 203480 THERAPEUTICE USE: - ANTIHYPERLIPO PROTEINEMIC. COMMERCIAL & CUSTOM INVO ICE NO. F22487001150 DT. 30.0 9.2023 F22487001163 DT. 30.09 .2023 F22487001167 DT. 30.09. 2023 F22487001173 DT. 30.09.2 MNBU0239597 001 023 F22487001174 DT. 30.09.20 23 F22487001175 DT. 30.09.202 3 F22487001183 DT. 30.09.2023 F22487001184 DT. 30.09.2023 F22487001188 DT. 30.09.2023 F22487001191 DT. 30.09.2023 F 22487001192 DT. 30.09.2023 F2 2487001193 DT. 30.09.2023 F22 MNBU0239597 001 487001194 DT. 30.09.2023 F224 87001197 DT. 30.09.2023 F2248 7001198 DT. 30.09.2023 S/BILL NO: 4015337 DT: 04.10.2023 S /BILL NO: 4015336 DT: 04.10.20

38 PALLETS 2370 CARTONS PH ARMACEUTICALS AS UNDER POTA SSIUM CL ER CAP 10MEQ 100 NDC CODE:68462035701 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO .:202868 THERAPEUTICE USE: - MNBU0523406 001 TREATMENT OR PREVENTION OF HYPOKALEMIA INDOMETHACIN ER CAP 75MG 100 NDC CODE:684620 32501 FDA PRODUCT CODE NO.: 62GCE42 H. T. S NO.: 3004.90 .92.40 ANDA NO.: 203501 THER APEUTICE USE: :#INDOMETHACIN IS USED TO RELIEVE PAIN, SWE MNBU0523406 001 LLING,AND JOINT STIFFNESS CAU SED BY ARTHRITIS, GOUT, BURS ITIS,AND TENDONITIS.AND TEND ONITIS.IT IS ALSO USED TO REL IEVE PAIN FROM VARIOUS AS DEC REASE SWELLING ANDTHIS EFFECT HELPS TOANTI-INFLAMMATORY D RUGA NONSTEROIDALTHIS MEDICAT MNBU0523406 001 ION IS KNOWNCONDITIONS. IN DOMETHACIN ER CAP 75MG 60 NDC CODE:68462032560 FDA PRODUCT CODE: 62 GCE42 H. T. S NO. :3004.90.92.40 ANDA NO.203501 THERAPEUTIC USE: INDOMETHAC IN IS USED TO RELIEVE PAIN, S WELLING, AND JOINT STIFFNESS MNBU0523406 001 CAUSED BY ARTHRITIS, GOUT, BU RSITIS, AND TENDONITIS. IT I S ALSO USED TO RELIEVE PAIN F ROM VARIOUS OTHER CONDITIONS. THIS MEDICATION IS KNOWN AS A NONSTEROIDAL ANTI-INFLAMMA TORY DRUG (NSAID). ... THIS EFFECT HELPS TO DECREASE SWEL MNBU0523406 001 LING AND PAIN. CARVEDILOL TAB 25MG 500 NDC CODE:6846201 6505 FDA PRODUCT CODE NO : 6 2 O C A 22 H. T. S NO.: 3004 .90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRE NOACEPTOR ANTAGONIST INDOM ETHACIN ER CAP 75MG 60 NDC CO MNBU0523406 001 DE:68462032560 FDA PRODUCT CO DE: 62 GCE42 H. T. S NO.:30 04.90.92.40 ANDA NO.203501 T HERAPEUTIC USE: INDOMETHACIN IS USED TO RELIEVE PAIN, SWEL LING, AND JOINT STIFFNESS CAU SED BY ARTHRITIS, GOUT, BURSI TIS, AND TENDONITIS. IT IS A MNBU0523406 001 LSO USED TO RELIEVE PAIN FROM VARIOUS OTHER CONDITIONS. T HIS MEDICATION IS KNOWN AS A NONSTEROIDAL ANTI-INFLAMMATOR Y DRUG (NSAID). ... THIS EFF ECT HELPS TO DECREASE SWELLIN G AND PAIN. ASPIRIN-ER DIP YRIDAMOLE CAP 25/200MG 60 NDC MNBU0523406 001 CODE:68462040560 FDA PRODUCT CODE NO.: 60 L D F 05 H. T. S NO.: 3004.90.9220 ANDA NO .:210318 TACROLIMUS CAP 1MG 100 NDC CODE:68462068601 HT S NO: 3004.90.92.15 FDA CODE : 64 T C E 08 ANDA NO.206662 THERAPEUTIC USE : TO PREVENT MNBU0523406 001 REJECTION OF A KIDNEY,HEART, OR LIVER TRANSPLANT TACRO LIMUS OINT 0.1% 100GM NDC COD E:68462053494 FDA PRODUCT COD E NO.: 64 T C J 08 H. T. S N O.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE: - T ACROLIMUS IS A TOPICAL IMMUNO MNBU0523406 001 SUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERATE-T O-SEVERE ATOPIC DERMATITIS ( ECZEMA). SEVELAMER HCL TAB 800MG 180 NDC CODE:6846204471 8 FDA PRODUCT CODE NO.: 63 L D A 04 H. T. S NO.: 3004.90 .92.60 ANDA NO.:204724 THERA MNBU0523406 001 PEUTICE USE:SEVELAMER HYDROC HLORIDE TABLETS ARE A PHOSPHA TE BINDER INDICATED FOR THE C ONTROL OF SERUM PHOSPHORUS IN PATIENTS WITH CHRONIC KIDNE Y DISEASE ON DIALYSIS PROP AFENONE HCL ER CAP 225MG 60 N DC CODE:68462040860 FDA PRODU MNBU0523406 001 CT CODE NO.: 63 E C F 28 H. T. S NO.: 3004.49.00.10 ANDA NO.:205268 THERAPEUTICE USE: AN ANTIARRHYTHMIC AGENT. IT IS USED TO TREAT IRREGULAR HE ART RHYTHM AND CAN SLOW RAPI D HEARTBEATS COMMERCIAL & CUSTOM INVOICE NO. F224870011 MNBU0523406 001 00 DT. 22.09.2023 F2248700110 1 DT. 22.09.2023 F22487001102 DT. 22.09.2023 F22487001103 DT. 22.09.2023 F22487001104 D T. 22.09.2023 F22487001105 DT . 22.09.2023 S/BILL NO: 40145 60 DT: 23/09/2023 S/BILL NO: 4014554 DT: 23/09/2023 S/BILL MNBU0523406 001 NO: 4014553 DT: 23/09/2023 S /BILL NO: 4014549 DT: 23/09/20 23 S/BILL NO: 4014551 DT: 23/ 09/2023 S/BILL NO: 4014550 DT : 23/09/2023 NET WT. 4287.102 KGS 03 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NO TIFY PARTY:2 GLENMARK PHARMAC MNBU0523406 001 EUTICALS INC 750, CORPORATE D RIVE, NEW JERSEY MAHWAH - 07 430 USA NOTIFY PARTY:3 GLEN MARK SPECIALTY S.A. SWITZERLA ND (GSSA) PLACE DU PORT 2 NE UCHATEL - 2000 SWITZERLAND

36 PALLETS 2787 CARTONS PH ARMACEUTICALS AS UNDER EZET IMIBE-SIMVA TAB 10/20MG 30 ND C CODE:68462032230 FDA PRODUC T CODE NO.: 61 J D C 15 H. T . S NO.: 3004.49.00.10 ANDA NO.: 208699 THERAPEUTICE USE: MNBU0484399 001 :#LIPID LOWERING AGENT EZ ETIMIBE-SIMVA TAB 10/20MG 90 NDC CODE:68462032290 FDA PROD UCT CODE NO.: 61 J D C 15 H. T. S NO.: 3004.49.00.10 AND A NO.: 208699 THERAPEUTICE US E: :#LIPID LOWERING AGENT RANOLAZINE ER TAB 500MG 60 ND MNBU0484399 001 C CODE:68462031960 FDA PRODUC T CODE NO.: 61 D C B 02 H. T . S NO.: 3004.49.00.10 ANDA NO.:211082 THERAPEUTIC USE: - IT IS AN ANTI-ANGINAL MEDIC ATION. IT WORKS BY IMPROVING BLOOD FLOW TO HELP THE HEART WORK MORE EFFICIENTLY. IT IS MNBU0484399 001 USED TO TREAT CHRONIC ANGINA (CHEST PAIN). IT IS NOT FOR USE DURING AN ACUTE (EMERGENC Y) ATTACK OF ANGINA PRAVAS TATIN SOD TAB 10MG 500 NDC CO DE:68462019505 FDA PRODUCT CO DE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: MNBU0484399 001 -77-987 THERAPEUTICE USE:-HY POLIPDAEMIC TACROLIMUS CAP 1MG 100 NDC CODE:68462068601 HTS NO: 3004.90.92.15 FDA CO DE : 64 T C E 08 ANDA NO.2066 62 THERAPEUTIC USE : TO PREV ENT REJECTION OF A KIDNEY,HEA RT, OR LIVER TRANSPLANT TA MNBU0484399 001 CROLIMUS OINT 0.1% 100GM NDC CODE:68462053494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO .: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMM UNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERAT MNBU0484399 001 E-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). CARVEDILOL TAB 25MG 500 NDC CODE:68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90. 92.20 ANDA NO.:- 78-251 THER APEUTICE USE:-BETA- ADRENOAC EPTOR ANTAGONIST CARVEDILO MNBU0484399 001 L TAB 25MG 500 NDC CODE:68462 016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 30 04.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- AD RENOACEPTOR ANTAGONIST COM MERCIAL & CUSTOM INVOICE NO. F22487001057 DT. 18.09.2023 F MNBU0484399 001 22487001058 DT. 18.09.2023 F2 2487001059 DT. 18.09.2023 F22 487001060 DT. 18.09.2023 F224 87001064 DT. 18.09.2023 F2248 7001065 DT. 18.09.2023 F22487 001068 DT. 18.09.2023 S/BILL NO:4014260 DT: 18/09/2023 S/B ILL NO: 4014262 DT: 18/09/2023 MNBU0484399 001 S/BILL NO: 4014264 DT: 18/09 /2023 S/BILL NO: 4014266 DT: 18/09/2023 S/BILL NO: 4014261 DT: 18/09/2023 S/BILL NO: 40 14265 DT: 18/09/2023 S/BILL N O: 4014263 DT: 18/09/2023 NET WT. 6171.094 KGS 00 DATA LO GGERS SET TEMPERATURE : +18 MNBU0484399 001 DEGREES NOTIFY PARTY:2 GL ENMARK PHARMACEUTICALS INC 75 0, CORPORATE DRIVE, NEW JERSE Y MAHWAH - 07430 USA

10 PALLETS 787 CARTONS PHA RMACEUTICALS AS UNDER PIMEC ROLIMUS CREAM 1% 30GM NDC COD E:68462060935 FDA PRODUCT COD E NO.: 61 S C J 04 H. T. S N O.: 3004.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE: - AS MNBU0471766 001 SECOUND-LINE THERAPY FOR TH E SHORT-TERM AND NON-CONTINUO S CHRONIC TRERTMENT OF MILD T O MODERATE ATOPIC DERMATITIS IN NON- IMMUNOCOMPROMISED ADULT AND CHILDREN 2 YEARS OF AGE CARVEDILOL TAB 25MG 50 0 NDC CODE:68462016505 FDA P MNBU0471766 001 RODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTIC E USE:-BETA- ADRENOACEPTOR ANTAGONIST CARVEDILOL TAB 2 5MG 500 NDC CODE:68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.9 MNBU0471766 001 2.20 ANDA NO.:- 78-251 THERA PEUTICE USE:-BETA- ADRENOACE PTOR ANTAGONIST COMMERCIAL & CUSTOM INVOICE NO. F224870 00989 DT. 31.08.2023 F2248700 0998 DT. 31.08.2023 F22487001 003 DT. 31.08.2023 S/BILL NO: 4013546 DT: 05/09/2023 S/BIL MNBU0471766 001 L NO:4013548 DT: 05/09/2023 S /BILL NO: 4013547 DT: 05/09/20 23 NET WT. 2560.957 KGS 04 D ATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH - 07430 USA

33 PALLETS 2431 CARTONS PH ARMACEUTICALS AS UNDER RANO LAZINE ER TAB 1000MG 60 NDC C ODE:68462032060 FDA PRODUCT C ODE NO.: 61 D C B 02 H. T. S NO.: 3004.49.00.10 ANDA NO. :211082 THERAPEUTIC USE: - IT MNBU0603097 001 IS AN ANTI-ANGINAL MEDICATI ON. IT WORKS BY IMPROVING BLO OD FLOW TO HELP THE HEART WOR K MORE EFFICIENTLY. IT IS USE D TO TREAT CHRONIC ANGINA (C HEST PAIN). IT IS NOT FOR USE DURING AN ACUTE (EMERGENCY) ATTACK OF ANGINA NAPROXEN MNBU0603097 001 SOD TAB 550MG 100 NDC CODE:68 462017901 FDA PRODUCT CODE N O.:-62 G C A 50 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-3 14 THERAPEUTICE USE:-ANTI -I NFLAMMATORY, ANALGESIC FENO FIBRATE CAP 134MG 100 NDC COD E:68462058101 FDA PRODUCT COD MNBU0603097 001 E NO.: 61 JCE 09 H. T. S NO. : 3004.90.92.20 ANDA NO.: 20 5566 THERAPEUTICE USE: - IND ICATED AS ADJUNCTIVE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, TOTAL-C, TRIGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMARY HYPERCHOLESTEROL MNBU0603097 001 EMIA OR MIXED DYSLIPIDEMIA CARVEDILOL TAB 25MG 500 NDC CODE:68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO .:- 78-251 THERAPEUTICE USE: -BETA- ADRENOACEPTOR ANTAGON IST TACROLIMUS CAP 5MG 100 MNBU0603097 001 NDC CODE:68462068701 HTS NO: 3004.90.92.15 FDA CODE : 64 T C E 08 ANDA NO.206662 THER APEUTICE USE: TO PREVENT REJE CTION OF A KIDNEY, HEART, OR LIVER TRANSPLANT PIMECROLI MUS CREAM 1% 100GM NDC CODE:6 8462060994 FDA PRODUCT CODE N MNBU0603097 001 O.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 211 769 THERAPEUTICE USE: - AS S ECOUND-LINE THERAPY FOR THE S HORT-TERM AND NON-CONTINUOS C HRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERMATITIS IN NONIMMUNOCOMPROMISED ADULT MNBU0603097 001 AND CHILDREN 2 YEARS OF AGE PIMECROLIMUS CREAM 1% 30GM NDC CODE:68462060935 FDA PROD UCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 AND A NO.: 211769 THERAPEUTICE US E: - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-C MNBU0603097 001 ONTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DER MATITIS IN NON- IMMUNOCOMPR OMISED ADULT AND CHILDREN 2 YEARS OF AGE POTASSIUM CL E R CAP 10MEQ 500 NDC CODE:6846 2035705 FDA PRODUCT CODE NO.: 65 R C F 14 H. T. S NO.: 3 MNBU0603097 001 004.90.92.90 ANDA NO.: 202868 THERAPEUTICE USE: - TREATME NT OR PREVENTION OF HYPOKALEM IA CARVEDILOL TAB 25MG 500 NDC CODE:68462016505 FDA PRO DUCT CODE NO : 62 O C A 22 H . T. S NO.: 3004.90.92.20 AN DA NO.:- 78-251 THERAPEUTICE MNBU0603097 001 USE:-BETA- ADRENOACEPTOR AN TAGONIST COMMERCIAL & CUSTO M INVOICE NO. F22487000922 DT . 22.08.2023 F22487000924 DT. 22.08.2023 F22487000925 DT. 23.08.2023 F22487000928 DT. 2 3.08.2023 F22487000929 DT. 23 .08.2023 S/BILL NO: 4012795 D MNBU0603097 001 T: 23.08.2023 S/BILL NO: 4012 793 DT: 23.08.2023 S/BILL NO: 4012792 DT: 23.08.2023 S/BIL L NO: 4012797 DT: 23.08.2023 S/BILL NO: 4012798 DT: 23.08.2 023 NET WT. 6847.701 KGS 0 2 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES MNBU0603097 001 TEMPERATURE RANGE : +15 DEGRE ES TO +25 DEGREES NOTIFY PART Y:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NE W JERSEY MAHWAH - 07430 USA

32 PALLETS 2157 CARTONS PHA RMACEUTICALS AS UNDER GABAP ENTIN TAB 600MG 500 NDC CODE: 68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77- 662 THERAPEUTICE USE:-ANTICO MNBU0250826 001 NVULSANT AGENT PRAVASTATIN SOD TAB 80MG 90 NDC CODE:684 62019890 FDA PRODUCT CODE NO .:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.:-77-98 7 THERAPEUTICE USE:-HYPOLIPD AEMIC POTASSIUM CL ER CAP 1 0MEQ 500 NDC CODE:68462035705 MNBU0250826 001 FDA PRODUCT CODE NO.: 65 R C F 14 H. T. S NO.: 3004.90. 92.90 ANDA NO.: 202868 THERA PEUTICE USE: - TREATMENT OR P REVENTION OF HYPOKALEMIA P OTASSIUM CL ER CAP 10MEQ 100 NDC CODE:68462035701 FDA PROD UCT CODE NO.:65 R C F 14 H. MNBU0250826 001 T. S NO.: 3004.90.92.90 ANDA NO.:202868 THERAPEUTICE USE: - TREATMENT OR PREVENTION O F HYPOKALEMIA PIMECROLIMUS CREAM 1% 30GM NDC CODE:68462 060935 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 30 04.90.92.45 ANDA NO.: 211769 MNBU0250826 001 THERAPEUTICE USE: - AS SECOU ND-LINE THERAPY FOR THE SHORT -TERM AND NON-CONTINUOS CHRON IC TRERTMENT OF MILD TO MODE RATE ATOPIC DERMATITIS IN NO N- IMMUNOCOMPROMISED ADULT A ND CHILDREN 2 YEARS OF AGE PIMECROLIMUS CREAM 1% 60GM N MNBU0250826 001 DC CODE:68462060965 FDA PRODU CT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE : - AS SECOUND-LINE THERAPY F OR THE SHORT-TERM AND NON-CO NTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERM MNBU0250826 001 ATITIS IN NON- IMMUNOCOMPROM ISED ADULT AND CHILDREN 2 YE ARS OF AGE EZETIMIBE TAB 10 MG 90 NDC CODE:68462022690 F DA PRODUCT CODE NO.: 61 J C A 15 H. T. S NO.: 3004.49.00. 10 ANDA NO.: #078560 THERAPE UTICE USE: LIPID LOWERING AGE MNBU0250826 001 NT 02 DATA LOGGERS SET T EMPERATURE : +18 DEGREES NET WT:4386.002KGS COMMERCIAL & C USTOM INVOICE NO. F2248700088 7 DT. 17.08.2023 F22487000888 DT. 17.08.2023 F22487000891 DT. 17.08.2023 F22487000893 D T. 17.08.2023 F22487000894 DT MNBU0250826 001 . 17.08.2023 S/BILL NO:401247 7 DT:17.08.2023 S/BILL NO:401 2467 DT:17.08.2023 S/BILL NO: 4012469 DT:17.08.2023 S/BILL NO:4012472 DT:17.08.2023 S/BI LL NO:4012468 DT:17.08.2023 N OTIFY PARTY:2 GLENMARK PHARMA CEUTICALS INC 750, CORPORATE MNBU0250826 001 DRIVE, NEW JERSEY MAHWAH - 0 7430 USA

21 PALLETS 1143 CARTONS PH ARMACEUTICALS AS UNDER TACR OLIMUS OINT 0.1% 60GM NDC COD E:68462053465 FDA PRODUCT COD E NO.: 64 T C J 08 H. T. S N O.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE: - T MNBU0329812 001 ACROLIMUS IS A TOPICAL IMMUNO SUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERATE-T O-SEVERE ATOPIC DERMATITIS ( ECZEMA). TACROLIMUS CAP 1MG 100 NDC CODE:68462068601 HT S NO: 3004.90.92.15 FDA CODE : 64 T C E 08 ANDA NO.206662 MNBU0329812 001 THERAPEUTIC USE : TO PREVENT REJECTION OF A KIDNEY,HEART, OR LIVER TRANSPLANT PRAVA STATIN SOD TAB 20MG 500 NDC C ODE:68462019605 FDA PRODUCT C ODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO. :-77-987 THERAPEUTICE USE:-H MNBU0329812 001 YPOLIPDAEMIC PROCHLORPERAZI NE MAL TAB 10MG 100 NDC CODE: 68462089001 CLINDAMYCIN HCL CAP 300MG 100 NDC CODE:68462 014401 FDA PRODUCT CODE NO.: 56 J C E 20 H. T. S NO.: 294 1.90.5000 ANDA NO.:216957 TH ERAPEUTICE USE: :#ANTI-INFECT MNBU0329812 001 IVE AGENT TACROLIMUS OINT 0 .1% 100GM NDC CODE:6846205349 4 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49 .00.50 ANDA NO.: 210393 THER APEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATM MNBU0329812 001 ENT OF MODERATE-TO-SEVERE AT OPIC DERMATITIS (ECZEMA). COMMERCIAL & CUSTOM INVOICE NO . F22487000819 DT. 31.07.2023 F22487000823 DT. 31.07.2023 F22487000855 DT. 04.08.2023 F22487000856 DT. 04.08.2023 F 22487000857 DT. 04.08.2023 F2 MNBU0329812 001 2487000858 DT. 04.08.2023 S/B ILL NO: 4011817 DT: 05.08.2023 S/BILL NO: 4011816 DT: 05.08 .2023 S/BILL NO: 4011824 DT: 05.08.2023 S/BILL NO: 4011820 DT: 05.08.2023 S/BILL NO: 40 11825 DT: 05.08.2023 S/BILL N O: 4011826 DT: 05.08.2023 NET MNBU0329812 001 WT. 2121.775 KGS 02 DATA LOGGERS SET TEMPERATURE : + 18 DEGREES NOTIFY PARTY :2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

23 PALLETS 1632 CARTONS PH ARMACEUTICALS AS UNDER GABA PENTIN TAB 600MG 500 NDC CODE :68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO. : 3004.90.92.30 ANDA NO.:-77 -662 THERAPEUTICE USE:-ANTIC MNBU4003784 001 ONVULSANT AGENT PRAVASTATI N SOD TAB 20MG 500 NDC CODE:6 8462019605 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.:-77- 987 THERAPEUTICE USE:-HYPOLI PDAEMIC TACROLIMUS CAP 1MG 100 NDC CODE:68462068601 HTS MNBU4003784 001 NO: 3004.90.92.15 FDA CODE : 64 T C E 08 ANDA NO.206662 THERAPEUTIC USE : TO PREVENT REJECTION OF A KIDNEY,HEART, OR LIVER TRANSPLANT TACROL IMUS OINT 0.1% 60GM NDC CODE: 68462053465 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO. MNBU4003784 001 : 3004.49.00.50 ANDA NO.: 21 0393 THERAPEUTICE USE: - TAC ROLIMUS IS A TOPICAL IMMUNOSU PPRESSIVE OINTMENT USED FOR T HE TREATMENT OF MODERATE-TO- SEVERE ATOPIC DERMATITIS (EC ZEMA). COMMERCIAL & CUSTOM INVOICE NO. F22487000872 DT. MNBU4003784 001 10.08.2023 F22487000874 DT. 1 0.08.2023 F22487000876 DT. 10 .08.2023 S/BILL NO: 4012113 DT: 10.08.2023 S/BILL NO: 401 2116 DT: 10.08.2023 S/BILL NO :4012117 DT: 10.08.2023 NET WT. 4142.243 KGS 02 DATA LOGG ERS HUMIDITY:65% SET TEMPERA MNBU4003784 001 TURE : +18 DEGREES TEMPERATUR E RANGE : +15 DEGREES TO +25 D EGREES NOTIFY PARTY:2 GLENMA RK PHARMACEUTICALS INC 750, C ORPORATE DRIVE, NEW JERSEY M AHWAH - 07430 USA

13 PALLETS 615 CARTONS PHARM ACEUTICALS AS UNDER PRAVASTAT IN SOD TAB 80MG 90 NDC CODE:6 8462019890 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.:-77- 987 THERAPEUTICE USE:-HYPOLI MNBU0415042 001 PDAEMIC EZETIMIBE-SIMVA TAB 10/80MG 90 NDC CODE:68462032 490 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO.: 3004. 49.00.10 ANDA NO.: 208699 TH ERAPEUTICE USE: - THIS COMBIN ATION MEDICATION IS USED TO H ELP LOWER BAD CHOLESTEROL AND MNBU0415042 001 FATS (SUCH AS LDL, TRIGLYCE RIDES) AND RAISE GOOD CHOLEST EROL (HDL) IN THE BLOOD. EZET IMIBE WORKS BY REDUCING THE AMOUNT OF CHOLESTEROL YOUR BO DY ABSORBS FROM YOUR DIET. SI MVASTATIN BELONGS TO A GROUP OF DRUGS KNOWN AS "STATINS." MNBU0415042 001 IT WORKS BY REDUCING THE AMO UNT OF CHOLESTEROL MADE BY TH E LIVER. INDOMETHACIN ER CAP 75MG 60 NDC CODE:68462032560 FDA PRODUCT CODE: 62 GCE42 H. T. S NO.:3004.90.92.40 AN DA NO.203501 THERAPEUTIC USE: INDOMETHACIN IS USED TO REL MNBU0415042 001 IEVE PAIN, SWELLING, AND JOIN T STIFFNESS CAUSED BY ARTHRIT IS, GOUT, BURSITIS, AND TENDO NITIS. IT IS ALSO USED TO REL IEVE PAIN FROM VARIOUS OTHER CONDITIONS. THIS MEDICATION IS KNOWN AS A NONSTEROIDAL A NTI-INFLAMMATORY DRUG (NSAID) MNBU0415042 001 . ... THIS EFFECT HELPS TO D ECREASE SWELLING AND PAIN. T ACROLIMUS OINT 0.1% 100GM NDC CODE:68462053494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA N O.: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IM MNBU0415042 001 MUNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERA TE-TO-SEVERE ATOPIC DERMATITI S (ECZEMA). 02 DATA LOGGERS SET TEMPERATURE : +18 DEGRE ES COMMERCIAL & CUSTOM INVO ICE NO. F22487000718 DT. 12.0 7.2023 F22487000723 DT. 13.07 MNBU0415042 001 .2023 F22487000725 DT. 13.07. 2023 4010417 DT:13.07.2023 4 010415 DT:13.07.2023 4010414 DT:13.07.2023 NET WT:1831.799 KGS NOTIFY PARTY:2 SHOROUQ COMMODITIES TRADING DMCC UNIT NO. 98, DMCC BUSINESS CENTRE, LEVEL NO. 8, JEWELLERY & GEM MNBU0415042 001 PLEX 2, DUBAI DUBA

6 PALLETS 162 CARTONS PHAR MACEUTICALS AS UNDER TACROL IMUS OINT 0.1% 100GM NDC CODE :68462053494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO .: 3004.49.00.50 ANDA NO.: 2 10393 THERAPEUTICE USE: - TA MNBU4319155 001 CROLIMUS IS A TOPICAL IMMUNOS UPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERATE-TO -SEVERE ATOPIC DERMATITIS (E CZEMA). S/BILL NO: 4009596 DT: 28.06.2023 COMMERCIAL & CUSTOM INVOICE NO. F22487000 609 DT. 28.06.2023 NET WT. 77 MNBU4319155 001 7.600 KGS 00 DATA LOGGERS HU MIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 SHOROUQ COMMO DITIES TRADING DMCC UNIT NO. 98, DMCC BUSINESS CENTRE, LEV EL NO. 8, JEWELLERY & GEMPLEX MNBU4319155 001 2, DUBAI DUBAI UTD.ARAB EMI R.

PHARMACEUTICALS AS UNDER GABAPENTIN TAB 60 0MG 500 NDC CODE:68462012605 FDA PRODUCT CO DE NO: 61 N C A 69 H. T. S NO.: 3004.90.92 .30 ANDA NO.:-77-662 THERAPEUTICE USE:-ANT ICONVULSANT AGENT EZETIMIBE TAB 10MG 90 NDC CODE:68462022690 FDA PRODUCT CODE NO.: 61 J C A 15 H. T. S NO.: 3004.49.00.10 AND HLBU9238885 001 A NO.: #078560 THERAPEUTICE USE: LIPID LOWE RING AGENT GABAPENTIN TAB 600MG 500 NDC C ODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.: -77-662 THERAPEUTICE USE:-ANTICONVULSANT A GENT TACROLIMUS OINT 0.1% 60GM NDC CODE:6 8462053465 FDA PRODUCT CODE NO.: 64 T C J 0 8 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210 HLBU9238885 001 393 THERAPEUTICE USE: - TACROLIMUS IS A TOP ICAL IMMUNOSUPPRESSIVE OINTMENT USED FOR TH E TREATMENT OF MODERATE-TO-SEVERE ATOPIC D ERMATITIS (ECZEMA). TACROLIMUS OINT 0.1% 100GM NDC CODE:68462053494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00. 50 ANDA NO.: 210393 THERAPEUTICE USE: - TA CROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OIN HLBU9238885 001 TMENT USED FOR THE TREATMENT OF MODERATE-TO -SEVERE ATOPIC DERMATITIS (ECZEMA). 00 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREE S TO +25 DEGREES

23 PALLETS 1000 CARTONS PHAR MACEUTICALS AS UNDER GABAPENT IN TAB 600MG 500 NDC CODE:684 62012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3 004.90.92.30 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVU MNBU0283250 001 LSANT AGENT METFORMIN HCL ER TAB (Z) 1000MG 90 NDC CODE:6 8462052190 FDA PRODUCT CODE N O.: 61 P C A 55 H. T. S NO.: 3004.90.92.40 ANDA NO.:2129 69 THERAPEUTICE USE: THE MAN AGEMENT OF TYPE 2 DIABETES N APROXEN SOD TAB 275MG 100 NDC MNBU0283250 001 CODE:68462017801 FDA PRODUCT CODE NO.:-62 G C A 50 H. T. S NO.: 3004.90.92.40 ANDA N O.:-78-314 THERAPEUTICE USE:- ANTI -INFLAMMATORY, ANALGESIC TOPIRAMATE ER CAP (Q) 100MG 30 NDC CODE:68462037430 3004 .49.00.20 61 M C B 40 210278 MNBU0283250 001 TACROLIMUS OINT 0.1% 60GM N DC CODE:68462053465 FDA PRODU CT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE : - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT US ED FOR THE TREATMENT OF MODE MNBU0283250 001 RATE-TO-SEVERE ATOPIC DERMATI TIS (ECZEMA). 02 DATA LOGG ERS HUMIDITY:65% SET TEMPERA TURE : +18 DEGREES TEMPERAT URE RANGE : +15 DEGREES TO + 25 DEGREES COMMERCIAL & CUSTO M INVOICE NO. F22487000555 DT . 20.06.2023 F22487000556 DT. MNBU0283250 001 20.06.2023 F22487000557 DT. 20.06.2023 F22487000562 DT. 2 1.06.2023 NOTIFY PARTY:2 GLE NMARK PHARMACEUTICALS INC 750 , CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

38 PALLETS 1951 CARTONS PH ARMACEUTICALS AS UNDER GABA PENTIN TAB 600MG 500 NDC CODE :68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO. : 3004.90.92.30 ANDA NO.:-77 -662 THERAPEUTICE USE:-ANTIC MNBU0535670 001 ONVULSANT AGENT TACROLIMUS CAP 5MG 100 NDC CODE:6846206 8701 HTS NO: 3004.90.92.15 F DA CODE : 64 T C E 08 ANDA NO .206662 THERAPEUTICE USE: TO PREVENT REJECTION OF A KIDNE Y, HEART, OR LIVER TRANSPLANT TACROLIMUS OINT 0.1% 100GM MNBU0535670 001 NDC CODE:68462053494 FDA PR ODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 A NDA NO.: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICA L IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF M ODERATE-TO-SEVERE ATOPIC DERM MNBU0535670 001 ATITIS (ECZEMA). PROPAFENO NE HCL ER CAP 225MG 60 NDC CO DE:68462040860 FDA PRODUCT CO DE NO.: 63 E C F 28 H. T. S NO.: 3004.49.00.10 ANDA NO.: 205268 THERAPEUTICE USE:AN A NTIARRHYTHMIC AGENT. IT IS US ED TO TREAT IRREGULAR HEART R MNBU0535670 001 HYTHM AND CAN SLOW RAPID HE ARTBEATS PROPAFENONE HCL ER CAP 325MG 60 NDC CODE:684620 40960 FDA PRODUCT CODE NO.: 63 E C F 28 H. T. S NO.: 300 4.49.00.10 ANDA NO.: 205268 THERAPEUTICE USE: -AN ANTIARR HYTHMIC AGENT IT IS USED TO T MNBU0535670 001 REAT IRREGULAR HEARTRHYTHM AN D CAN SLOW RAPID HEARTBEATS TACROLIMUS OINT 0.1% 100GM NDC CODE:68462053494 FDA PROD UCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 AND A NO.: 210393 THERAPEUTICE US E: - TACROLIMUS IS A TOPICAL MNBU0535670 001 IMMUNOSUPPRESSIVE OINTMENT U SED FOR THE TREATMENT OF MOD ERATE-TO-SEVERE ATOPIC DERMAT ITIS (ECZEMA). DILTIAZEM H CL ER CAP 12HR 60MG 100 NDC C ODE:68462085001 62 O C B 24 3004.49.00.10 212317 FOR THE TREATMENT OF HYPERTENSION. MNBU0535670 001 CARVEDILOL TAB 25MG 500 NDC CODE:68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA N O.:- 78-251 THERAPEUTICE USE :-BETA- ADRENOACEPTOR ANTAGO NIST POTASSIUM CL ER CAP 10 MEQ 100 NDC CODE:68462035701 MNBU0535670 001 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92 .90 ANDA NO.:202868 THERAPEU TICE USE: - TREATMENT OR PREV ENTION OF HYPOKALEMIA CAR VEDILOL TAB 25MG 500 NDC CODE :68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO MNBU0535670 001 .: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BET A- ADRENOACEPTOR ANTAGONIST COMMERCIAL & CUSTOM INVOICE NO. F22487000167 DT. 30.04.2 023 F22487000172 DT. 30.04.20 23 F22487000178 DT. 30.04.202 3 F22487000179 DT. 30.04.2023 MNBU0535670 001 F22487000180 DT. 30.04.2023 F22487000181 DT. 30.04.2023 F22487000186 DT. 30.04.2023 S/BILL NO: 4006447 DT: 04.05. 2023 S/BILL NO: 4006448 DT: 0 4.05.2023 S/BILL NO: 4006449 DT: 04.05.2023 S/BILL NO: 400 6450 DT: 04.05.2023 S/BILL NO MNBU0535670 001 : 4006451 DT: 04.05.2023 S/BI LL NO: 4006453 DT: 04.05.2023 S/BILL NO: 4006452 DT: 04.05. 2023 NET WT.6487.98 00 DATA LOGGERS HUMIDITY:65% SE T TEMPERATURE : +18 DEGREES T EMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY: MNBU0535670 001 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

41 PALLETS 2175 CARTONS PH ARMACEUTICALS AS UNDER GABA PENTIN TAB 600MG 500 NDC CODE :68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO. : 3004.90.92.30 ANDA NO.:-77 -662 THERAPEUTICE USE:-ANTIC MNBU0147079 001 ONVULSANT AGENT CARVEDILOL TAB 12.5MG 100 NDC CODE:6846 2016401 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3 004.90.92.20 ANDA NO.:- 78-25 1 THERAPEUTICE USE:-BETA- A DRENOACEPTOR ANTAGONIST PR AVASTATIN SOD TAB 20MG 500 ND MNBU0147079 001 C CODE:68462019605 FDA PRODUC T CODE NO.:-61 J C A 13 H. T . S NO.: 3004.90.92.20 ANDA NO.:-77-987 THERAPEUTICE USE :-HYPOLIPDAEMIC CARVEDILOL TAB 12.5MG 500 NDC CODE:68462 016405 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 30 MNBU0147079 001 04.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- AD RENOACEPTOR ANTAGONIST CAR VEDILOL TAB 25MG 500 NDC CODE :68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO .: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BET MNBU0147079 001 A- ADRENOACEPTOR ANTAGONIST TACROLIMUS OINT 0.1% 100GM NDC CODE:68462053494 FDA PRO DUCT CODE NO.: 64 T C J 08 H . T. S NO.: 3004.49.00.50 AN DA NO.: 210393 THERAPEUTICE U SE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT MNBU0147079 001 USED FOR THE TREATMENT OF MO DERATE-TO-SEVERE ATOPIC DERMA TITIS (ECZEMA). POTASSIUM CL ER CAP 10MEQ 100 NDC CODE: 68462035701 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO.:2028 68 THERAPEUTICE USE: - TREAT MNBU0147079 001 MENT OR PREVENTION OF HYPOKA LEMIA COMMERCIAL & CUSTOM I NVOICE NO. F22487000157 DT. 2 9.04.2023 F22487000158 DT. 29 .04.2023 F22487000168 DT. 30. 04.2023 F22487000183 DT. 30.0 4.2023 F22487000190 DT. 30.04 .2023 S/BILL NO:4006413 DT: 0 MNBU0147079 001 4.05.2023 S/BILL NO:4006414 D T: 04.05.2023 S/BILL NO:40064 16 DT: 04.05.2023 S/BILL NO: 4006417 DT: 04.05.2023 S/BILL NO:4006418 DT: 04.05.2023 NE T WT.8495.324 02 DATA LOGGE RS HUMIDITY:65% SET TEMPERAT URE : +18 DEGREES TEMPERATURE MNBU0147079 001 RANGE : +15 DEGREES TO +25 DE GREES NOTIFY PARTY:2 GLENMAR K PHARMACEUTICALS INC 750, CO RPORATE DRIVE, NEW JERSEY MA HWAH - 07430 USA

27 PALLETS 1796 CARTONS P HARMACEUTICALS AS UNDER RAN OLAZINE ER TAB 500MG 60 NDC C ODE:68462031960 FDA PRODUCT C ODE NO.: 61 D C B 02 H. T. S NO.: 3004.49.00.10 ANDA NO. :211082 THERAPEUTIC USE: - IT MNBU0516618 001 IS AN ANTI-ANGINAL MEDICATI ON. IT WORKS BY IMPROVING BLO OD FLOW TO HELP THE HEART WOR K MORE EFFICIENTLY. IT IS USE D TO TREAT CHRONIC ANGINA (C HEST PAIN). IT IS NOT FOR USE DURING AN ACUTE (EMERGENCY) ATTACK OF ANGINA RANOLAZIN MNBU0516618 001 E ER TAB 1000MG 60 NDC CODE:6 8462032060 FDA PRODUCT CODE N O.: 61 D C B 02 H. T. S NO.: 3004.49.00.10 ANDA NO.:2110 82 THERAPEUTIC USE: - IT IS AN ANTI-ANGINAL MEDICATION. I T WORKS BY IMPROVING BLOOD FL OW TO HELP THE HEART WORK MOR MNBU0516618 001 E EFFICIENTLY. IT IS USED TO TREAT CHRONIC ANGINA (CHEST PAIN). IT IS NOT FOR USE DURI NG AN ACUTE (EMERGENCY) ATTAC K OF ANGINA EZETIMIBE-SIMV A TAB 10/40MG 30 NDC CODE:684 62032330 FDA PRODUCT CODE NO. : 61 J D C 15 H. T. S NO.: MNBU0516618 001 3004.49.00.10 ANDA NO.: 20869 9 THERAPEUTICE USE: - THIS C OMBINATION MEDICATION IS USED TO HELP LOWER BAD CHOLESTERO L AND FATS (SUCH AS LDL, TRI GLYCERIDES) AND RAISE GOOD CH OLESTEROL (HDL) IN THE BLOOD. EZETIMIBE WORKS BY REDUCING MNBU0516618 001 THE AMOUNT OF CHOLESTEROL YO UR BODY ABSORBS FROM YOUR DIE T. SIMVASTATIN BELONGS TO A G ROUP OF DRUGS KNOWN AS "STATI NS." IT WORKS BY REDUCING THE AMOUNT OF CHOLESTEROL MADE BY THE LIVER. TOPIRAMATE ER CAP (Q) 25MG 30 NDC CODE:684 MNBU0516618 001 62037230 3004.49.00.20 61 M C B 40 210278 RUFINAMIDE T AB 400MG 120 NDC CODE:6846207 1408 61 M C A 99 3004.90.92. 30 205075 TO USED WITH OTHER MEDICATIONS TO PREVENT OR C ONTROL SEIZURES (EPILEPSY) A SSOCIATED WITH LENNOX-GASTAUT MNBU0516618 001 SYNDROME (LGS FENOFIBRATE CAP 200MG 100 NDC CODE:68462 058201 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004 .90.92.20 ANDA NO.: 205566 T HERAPEUTICE USE: - INDICATED AS ADJUNCTIVE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, MNBU0516618 001 TOTAL-C, TRIGLYCERIDES AND A PO B IN DULT PATIENTS WITH P RMARY HYPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA CARVED ILOL TAB 12.5MG 500 NDC CODE: 68462016405 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO. : 3004.90.92.20 ANDA NO.:- 7 MNBU0516618 001 8-251 THERAPEUTICE USE:-BETA - ADRENOACEPTOR ANTAGONIST EZETIMIBE-SIMVA TAB 10/40MG 90 NDC CODE:68462032390 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: 208699 THERAPEUTIC E USE: :#LIPID LOWERING AGENT MNBU0516618 001 TACROLIMUS OINT 0.1% 100GM NDC CODE:68462053494 FDA PR ODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 A NDA NO.: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICA L IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF M MNBU0516618 001 ODERATE-TO-SEVERE ATOPIC DERM ATITIS (ECZEMA). 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREE S TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES COM MERCIAL & CUSTOM INVOICE NO. F22487000139 DT. 26.04.2023 F MNBU0516618 001 22487000141 DT. 26.04.2023 F2 2487000142 DT. 26.04.2023 S /BILL NO:4005995 DT:27.04.2023 S/BILL NO:4005998 DT:27.04.2 023 S/BILL NO:4006001 DT:27.0 4.2023 NET WT.:2452.388 NO TIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC MNBU0516618 001 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

PHARMACEUTICALS AS UNDER CLINDAMYCIN HCL C AP 150MG 100 NDC CODE:68462014301 CLINDAM YCIN HCL CAP 150MG 500 NDC CODE:68462014305 POTASSIUM CL ER CAP 10MEQ 100 NDC CODE:68 462035701 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO.:202868 THERAPEUTICE USE: - TREATMENT OR PREVENTIO SZLU9440976 001 N OF HYPOKALEMIA CLINDAMYCIN HCL CAP 300 MG 100 NDC CODE:68462014401 TACROLIMUS OI NT 0.1% 30GM NDC CODE:68462053435 FDA PRODU CT CODE NO.: 64 T C J 08 H. T. S NO.: 3004 .49.00.50 ANDA NO.: 210393 THERAPEUTICE USE : - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSI VE OINTMENT USED FOR THE TREATMENT OF MODE RATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). SZLU9440976 001 CARVEDILOL TAB 12.5MG 500 NDC CODE:684620 16405 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANT AGONIST RANOLAZINE ER TAB 500MG 60 NDC CO DE:68462031960 FDA PRODUCT CODE NO.: 61 D C B 02 H. T. S NO.: 3004.49.00.10 ANDA NO.: 211082 THERAPEUTIC USE: - IT IS AN ANTI-ANG SZLU9440976 001 INAL MEDICATION. IT WORKS BY IMPROVING BLOO D FLOW TO HELP THE HEART WORK MORE EFFICIEN TLY. IT IS USED TO TREAT CHRONIC ANGINA (CH EST PAIN). IT IS NOT FOR USE DURING AN ACUTE (EMERGENCY) ATTACK OF ANGINA TACROLIMUS OINT 0.1% 60GM NDC CODE:68462053465 FDA PR ODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3 004.49.00.50 ANDA NO.: 210393 THERAPEUTICE SZLU9440976 001 USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRE SSIVE OINTMENT USED FOR THE TREATMENT OF M ODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA ). 02 DATA LOGGERS HUMIDITY:65% SE T TEMPERATURE : +20 DEGREES TEMPERATURE RANG E : +15 DEGREES TO +25 DEGREES CONTAINER NO. SZLU9440976 COMMERCIAL & CUSTOM INVOICE NO. F22387002459 DT. 31.03.2023 F2238700246 SZLU9440976 001 9 DT. 31.03.2023 F22387002472 DT. 31.03.2023 F22387002476 DT. 31.03.2023 F22387002490 D T. 31.03.2023 F22387002493 DT. 31.03.2023 F 22387002501 DT. 31.03.2023

35 PALLETS 2250 CARTONS PHARMACEUTICALS AS UNDER G ABAPENTIN TAB 600MG 500 NDC C ODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO. :-77-662 THERAPEUTICE USE:-A MNBU0295651 001 NTICONVULSANT AGENT RANOLA ZINE ER TAB 1000MG 60 NDC COD E:68462032060 FDA PRODUCT COD E NO.: 61 D C B 02 H. T. S N O.: 3004.49.00.10 ANDA NO.:2 11082 THERAPEUTIC USE: - IT I S AN ANTI-ANGINAL MEDICATION . IT WORKS BY IMPROVING BLOOD MNBU0295651 001 FLOW TO HELP THE HEART WORK MORE EFFICIENTLY. IT IS USED TO TREAT CHRONIC ANGINA (CHE ST PAIN). IT IS NOT FOR USE D URING AN ACUTE (EMERGENCY) AT TACK OF ANGINA TOPIRAMATE ER CAP (Q) 25MG 30 NDC CODE:6 8462037230 3004.49.00.20 61 MNBU0295651 001 M C B 40 210278 INDOMETHAC IN ER CAP 75MG 60 NDC CODE:68 462032560 FDA PRODUCT CODE: 6 2 GCE42 H. T. S NO.:3004.90 .92.40 ANDA NO.203501 THERAP EUTIC USE: INDOMETHACIN IS US ED TO RELIEVE PAIN, SWELLING, AND JOINT STIFFNESS CAUSED MNBU0295651 001 BY ARTHRITIS, GOUT, BURSITIS, AND TENDONITIS. IT IS ALSO U SED TO RELIEVE PAIN FROM VARI OUS OTHER CONDITIONS. THIS M EDICATION IS KNOWN AS A NONST EROIDAL ANTI-INFLAMMATORY DRU G (NSAID). ... THIS EFFECT H ELPS TO DECREASE SWELLING AND MNBU0295651 001 PAIN. FENOFIBRATE CAP 134 MG 100 NDC CODE:68462058101 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.2 0 ANDA NO.: 205566 THERAPEUT ICE USE: - INDICATED AS ADJUN CTIVE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, TOTAL-C MNBU0295651 001 , TRIGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMARY H YPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA TACROLIMUS OIN T 0.1% 30GM NDC CODE:68462053 435 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004. 49.00.50 ANDA NO.: 210393 TH MNBU0295651 001 ERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIV E OINTMENT USED FOR THE TREA TMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). TACROLIMUS OINT 0.1% 60GM N DC CODE:68462053465 FDA PRODU CT CODE NO.: 64 T C J 08 H. MNBU0295651 001 T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE : - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT US ED FOR THE TREATMENT OF MODE RATE-TO-SEVERE ATOPIC DERMATI TIS (ECZEMA). TACROLIMUS C AP 1MG 100 NDC CODE:684620686 MNBU0295651 001 01 HTS NO: 3004.90.92.15 FDA CODE : 64 T C E 08 ANDA NO.2 06662 THERAPEUTIC USE : TO P REVENT REJECTION OF A KIDNEY, HEART, OR LIVER TRANSPLANT INDOMETHACIN ER CAP 75MG 90 NDC CODE:68462032590 FDA PROD UCT CODE NO.: 62 GCE42 H. T. MNBU0295651 001 S NO.: 3004.90.92.40 ANDA N O.: 203501 THERAPEUTICE USE: #INDOMETHACIN IS USED TO REL IEVE PAIN, SWELLING AND JOINT STIFFNESS CAUSED BY ARTHRITI S, GOUT, BURSITIS AND TENDONI TIS IT IS ALSO USED TO RELIEV E PAIN FROM VARIOUS OTHER CO MNBU0295651 001 NDITIONS.THIS MEDICATION IS KNOWN AS A NONSTEROIDAL ANTI -INFLAMMATORY DRUG THIS EFFEC T HELPS TO DECREASE SWELLING AND PAIN. COMMERCIAL & CUS TOM INVOICE NO. F22387002162 DT. 22.02.2023 F22387002164 D T. 22.02.2023 F22387002169 DT MNBU0295651 001 . 23.02.2023 F22387002166 DT. 22.02.2023 F22387002165 DT. 22.02.2023 NET WT. 3678.343 KGS 02 DATA LOGGERS HUMIDIT Y:65% SET TEMPERATURE : +20 D EGREES TEMPERATURE RANGE : +1 5 DEGREES TO +25 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU MNBU0295651 001 TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 0 USA S/BILL NO: 4002607 D T: 23.02.2023 S/BILL NO: 4002 604 DT: 23.02.2023 S/BILL NO: 4002608 DT: 23.02.2023 S/BIL L NO: 4002603 DT: 23.02.2023 S/BILL NO: 4002605 DT: 23.02.2 MNBU0295651 001 023

37 PALLETS 3044 CARTONS PHARMACEUTICALS AS UNDER EZ ETIMIBE TAB 10MG 500 NDC CODE :68462022605 FDA PRODUCT CODE NO.: 61 J C A 15 H. T. S NO .: 3004.49.00.10 ANDA NO.: # 078560 THERAPEUTICE USE: LIPI MNBU0633070 001 D LOWERING AGENT EZETIMIBE TAB 10MG 90 NDC CODE:6846202 2690 FDA PRODUCT CODE NO.: 6 1 J C A 15 H. T. S NO.: 3004 .49.00.10 ANDA NO.: #078560 THERAPEUTICE USE: LIPID LOWER ING AGENT PROPAFENONE HCL E R CAP 225MG 60 NDC CODE:68462 MNBU0633070 001 040860 FDA PRODUCT CODE NO.: 63 E C F 28 H. T. S NO.: 30 04.49.00.10 ANDA NO.:205268 THERAPEUTICE USE:AN ANTIARRHY THMIC AGENT. IT IS USED TO TR EAT IRREGULAR HEART RHYTHM A ND CAN SLOW RAPID HEARTBEATS INDOMETHACIN ER CAP 75MG 9 MNBU0633070 001 0 NDC CODE:68462032590 FDA P RODUCT CODE NO.: 62 GCE42 H. T. S NO.: 3004.90.92.40 AND A NO.: 203501 THERAPEUTICE US E: #INDOMETHACIN IS USED TO RELIEVE PAIN, SWELLING AND JO INT STIFFNESS CAUSED BY ARTHR ITIS, GOUT, BURSITIS AND TEND MNBU0633070 001 ONITIS IT IS ALSO USED TO REL IEVE PAIN FROM VARIOUS OTHER CONDITIONS.THIS MEDICATION IS KNOWN AS A NONSTEROIDAL A NTI-INFLAMMATORY DRUG THIS EF FECT HELPS TO DECREASE SWELLI NG AND PAIN. FENOFIBRATE C AP 134MG 100 NDC CODE:6846205 MNBU0633070 001 8101 FDA PRODUCT CODE NO.: 6 1 JCE 09 H. T. S NO.: 3004.9 0.92.20 ANDA NO.: 205566 THE RAPEUTICE USE: - INDICATED AS ADJUNCTIVE THERAPY TO DIET F OR THE REDUCTION OF LDL-C, T OTAL-C, TRIGLYCERIDES AND APO B IN DULT PATIENTS WITH PRM MNBU0633070 001 ARY HYPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA COLESEVE LAM HCL TAB 625MG 180 NDC COD E:68462043318 FDA PRODUCT COD E NO.: 62 B D A 13 H. T. S N O.: 3004.49.00.10 ANDA NO.: 203480 THERAPEUTICE USE: - A NTIHYPERLIPO PROTEINEMIC. MNBU0633070 001 POTASSIUM CL ER CAP 10MEQ 500 NDC CODE:68462035705 FDA PRO DUCT CODE NO.: 65 R C F 14 H . T. S NO.: 3004.90.92.90 AN DA NO.: 202868 THERAPEUTICE U SE: - TREATMENT OR PREVENTION OF HYPOKALEMIA TACROLIMUS CAP 1MG 100 NDC CODE:6846206 MNBU0633070 001 8601 HTS NO: 3004.90.92.15 F DA CODE : 64 T C E 08 ANDA NO .206662 THERAPEUTIC USE : TO PREVENT REJECTION OF A KIDNE Y,HEART, OR LIVER TRANSPLANT TACROLIMUS OINT 0.1% 60GM NDC CODE:68462053465 FDA PROD UCT CODE NO.: 64 T C J 08 H. MNBU0633070 001 T. S NO.: 3004.49.00.50 AND A NO.: 210393 THERAPEUTICE US E: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT U SED FOR THE TREATMENT OF MOD ERATE-TO-SEVERE ATOPIC DERMAT ITIS (ECZEMA). COMMERCIAL & CUSTOM INVOICE NO. F2238700 MNBU0633070 001 2008 DT. 30.01.2023 F22387002 010 DT. 31.01.2023 F223870020 12 DT. 31.01.2023 S/BILL NO: 4001310 DT: 31.01.2023 S/BIL L NO:4001320 DT: 31.01.2023 S/BILL NO:4001330 DT: 31.01.2 023 NET WT. 3912.588 KGS 02 DATA LOGGERS HUMIDITY:65% SE MNBU0633070 001 T TEMPERATURE : +20 DEGREES T EMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

37 PALLETS 1886 CARTONS PHARMACEUTICALS AS UNDER TA CROLIMUS OINT 0.1% 30GM NDC C ODE:68462053435 FDA PRODUCT C ODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO. : 210393 THERAPEUTICE USE: - MNBU3867637 001 TACROLIMUS IS A TOPICAL IMMU NOSUPPRESSIVE OINTMENT USED F OR THE TREATMENT OF MODERATE -TO-SEVERE ATOPIC DERMATITIS (ECZEMA). TACROLIMUS OINT 0.1% 60GM NDC CODE:6846205346 5 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49 MNBU3867637 001 .00.50 ANDA NO.: 210393 THER APEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATM ENT OF MODERATE-TO-SEVERE AT OPIC DERMATITIS (ECZEMA). PRAVASTATIN SOD TAB 20MG 500 NDC CODE:68462019605 FDA PROD MNBU3867637 001 UCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 AND A NO.:-77-987 THERAPEUTICE U SE:-HYPOLIPDAEMIC PRAVASTAT IN SOD TAB 80MG 90 NDC CODE:6 8462019890 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.:-77- MNBU3867637 001 987 THERAPEUTICE USE:-HYPOLI PDAEMIC INDOMETHACIN ER CAP 75MG 60 NDC CODE:68462032560 FDA PRODUCT CODE: 62 GCE42 H. T. S NO.:3004.90.92.40 A NDA NO.203501 THERAPEUTIC USE : INDOMETHACIN IS USED TO RE LIEVE PAIN, SWELLING, AND JOI MNBU3867637 001 NT STIFFNESS CAUSED BY ARTHRI TIS, GOUT, BURSITIS, AND TEND ONITIS. IT IS ALSO USED TO RE LIEVE PAIN FROM VARIOUS OTHER CONDITIONS. THIS MEDICATION IS KNOWN AS A NONSTEROIDAL ANTI-INFLAMMATORY DRUG (NSAID ). ... THIS EFFECT HELPS TO MNBU3867637 001 DECREASE SWELLING AND PAIN. CARVEDILOL TAB 25MG 500 NDC CODE:68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA N O.:- 78-251 THERAPEUTICE USE :-BETA- ADRENOACEPTOR ANTAGO NIST PRAVASTATIN SOD TAB 20 MNBU3867637 001 MG 500 NDC CODE:68462019605 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92 .20 ANDA NO.:-77-987 THERAPE UTICE USE:-HYPOLIPDAEMIC T ACROLIMUS OINT 0.1% 60GM NDC CODE:68462053465 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. MNBU3867637 001 S NO.: 3004.49.00.50 ANDA NO .: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMM UNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERAT E-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). COMMERCIAL & CU STOM INVOICE NO. F22387001958 MNBU3867637 001 DT. 23.01.2023 F22387001961 DT. 23.01.2023 F22387001962 D T. 23.01.2023 F22387001965 DT . 23.01.2023 S/BILL NO: 400 0922 DT: 24.01.2023 S/BILL N O: 4000921 DT: 24.01.2023 S/ BILL NO: 4000926 DT: 24.01.20 23 S/BILL NO: 4000924 DT: 24 MNBU3867637 001 .01.2023 NET WT. 5931.653 KGS 02 DATA LOGGERS HUMIDIT Y:65% SET TEMPERATURE : +20 D EGREES TEMPERATURE RANGE : +1 5 DEGREES TO +25 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 MNBU3867637 001 0 USA

34 PALLETS 1855 CARTONS P HARMACEUTICALS AS UNDER GAB APENTIN TAB 600MG 500 NDC COD E:68462012605 FDA PRODUCT COD E NO: 61 N C A 69 H. T. S NO .: 3004.90.92.30 ANDA NO.:-7 7-662 THERAPEUTICE USE:-ANTI MNBU0486196 001 CONVULSANT AGENT TACROLIMU S OINT 0.1% 30GM NDC CODE:684 62053435 FDA PRODUCT CODE NO. : 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 21039 3 THERAPEUTICE USE: - TACROL IMUS IS A TOPICAL IMMUNOSUPPR ESSIVE OINTMENT USED FOR THE MNBU0486196 001 TREATMENT OF MODERATE-TO-SEV ERE ATOPIC DERMATITIS (ECZEM A). POTASSIUM CL ER CAP 10M EQ 100 NDC CODE:68462035701 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92. 90 ANDA NO.:202868 THERAPEUT ICE USE: - TREATMENT OR PREVE MNBU0486196 001 NTION OF HYPOKALEMIA CARV EDILOL TAB 25MG 500 NDC CODE: 68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO. : 3004.90.92.20 ANDA NO.:- 7 8-251 THERAPEUTICE USE:-BETA - ADRENOACEPTOR ANTAGONIST COMMERCIAL & CUSTOM INVOICE MNBU0486196 001 NO. F22387001914 DT. 14.01.20 23 F22387001931 DT. 17.01.202 3 F22387001932 DT. 17.01.2023 S/BILL NO:4000647 DT: 18.01. 2023 S/BILL NO: 4000650 DT: 1 8.01.2023 S/BILL NO: 4000651 DT: 18.01.2023 NET WT: 5195.3 41 KGS 02 DATA LOGGERS SE MNBU0486196 001 T TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK PHAR MACEUTICALS INC 750, CORPORAT E DRIVE, NEW JERSEY MAHWAH - 07430 USA

37 PALLETS 2426 CARTONS PHARMACEUTICALS AS UNDER GA BAPENTIN TAB 600MG 500 NDC CO DE:68462012605 FDA PRODUCT CO DE NO: 61 N C A 69 H. T. S N O.: 3004.90.92.30 ANDA NO.:- 77-662 THERAPEUTICE USE:-ANT MNBU9111190 001 ICONVULSANT AGENT TACROLIM US OINT 0.1% 30GM NDC CODE:68 462053435 FDA PRODUCT CODE NO .: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 2103 93 THERAPEUTICE USE: - TACRO LIMUS IS A TOPICAL IMMUNOSUPP RESSIVE OINTMENT USED FOR THE MNBU9111190 001 TREATMENT OF MODERATE-TO-SE VERE ATOPIC DERMATITIS (ECZE MA). PRAVASTATIN SOD TAB 10 MG 500 NDC CODE:68462019505 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92 .20 ANDA NO.:-77-987 THERAPE UTICE USE:-HYPOLIPDAEMIC P MNBU9111190 001 RAVASTATIN SOD TAB 20MG 500 N DC CODE:68462019605 FDA PRODU CT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.:-77-987 THERAPEUTICE US E:-HYPOLIPDAEMIC PROPAFENON E HCL ER CAP 425MG 60 NDC COD E:68462041060 FDA CODES 63 E MNBU9111190 001 C F 28 HTS CODES 3004.49.00. 10 ANDA NO. 205268 THERAPEUT IC USE AN ANTIARRHYTHMIC AGEN T.IT IS USED TO TREAT IRREGUL AR HEART RHYTHM AND CAN SLOW RAPID HEARTBEATS. POTASSIU M CL ER CAP 10MEQ 500 NDC COD E:68462035705 FDA PRODUCT COD MNBU9111190 001 E NO.: 65 R C F 14 H. T. S N O.: 3004.90.92.90 ANDA NO.: 202868 THERAPEUTICE USE: - T REATMENT OR PREVENTION OF HYP OKALEMIA FENOFIBRATE CAP 67 MG 100 NDC CODE:68462058001 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.2 MNBU9111190 001 0 ANDA NO.: 205566 THERAPEUT ICE USE: - INDICATED AS ADJUN CTIVE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, TOTAL-C , TRIGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMARY H YPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA GABAPENTIN TAB MNBU9111190 001 600MG 500 NDC CODE:684620126 05 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90 .92.30 ANDA NO.:-77-662 THER APEUTICE USE:-ANTICONVULSANT AGENT BISOPROLOL-HCTZ TAB 10/6.25MG 100 NDC CODE:684620 88001 FDA PRODUCT CODE NO.: MNBU9111190 001 62 O D A 18 H. T. S NO.: 300 4.40.00.20 ANDA NO.: 215995 THERAPEUTICE USE: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZ IDE TABLETS ARE INDICATED IN THE MANAGEMENT OF HYPERTENS ION. FENOFIBRATE CAP 67MG 1 00 NDC CODE:68462058001 FDA MNBU9111190 001 PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.20 A NDA NO.: 205566 THERAPEUTICE USE: - INDICATED AS ADJUNCTIV E THERAPY TO DIET FOR THE RE DUCTION OF LDL-C, TOTAL-C, TR IGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMARY HYPER MNBU9111190 001 CHOLESTEROLEMIA OR MIXED DYSL IPIDEMIA GABAPENTIN TAB 600 MG 500 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92. 30 ANDA NO.:-77-662 THERAPEU TICE USE:-ANTICONVULSANT AGE NT COMMERCIAL & CUSTOM INVO MNBU9111190 001 ICE NO. F22387001880 DT. 10.0 1.2023 F22387001879 DT. 10.01 .2023 F22387001877 DT. 10.01. 2023 F22387001875 DT. 10.01.2 023 F22387001882 DT. 11.01.20 23 F22387001885 DT. 11.01.202 3 NET WT.6729.197 KGS 02 DAT A LOGGERS NOTIFY PARTY:2 G MNBU9111190 001 LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA S/B ILL NO: 4000334 DT: 11.01.2023 S/BILL NO: 4000338 DT: 11.01 .2023 S/BILL NO: 4000335 DT: 11.01.2023 S/BILL NO: 4000336 DT: 11.01.2023 S/BILL NO: 40 MNBU9111190 001 00345 DT: 11.01.2023 S/BILL N O: 4000360 DT: 11.01.2023

15 PALLETS 964 CARTONS PHARMACEUTICALS AS UNDER EZETIMIBE-SIMVA TAB 10/10MG 30 NDC CODE:68462032130 FDA PR ODUCT CODE NO.: 61 J D C 15 H. T. S NO.: 3004.49.00.10 A NDA NO.: 208699 THERAPEUTICE MNBU0385164 001 USE: - THIS COMBINATION MEDIC ATION IS USED TO HELP LOWER BAD CHOLESTEROL AND FATS (SUC H AS LDL, TRIGLYCERIDES) AND RAISE GOOD CHOLESTEROL (HDL) IN THE BLOOD. EZETIMIBE WORK S BY REDUCING THE AMOUNT OF C HOLESTEROL YOUR BODY ABSORBS MNBU0385164 001 FROM YOUR DIET. SIMVASTATIN BELONGS TO A GROUP OF DRUGS K NOWN AS "STATINS." IT WORKS B Y REDUCING THE AMOUNT OF CHOL ESTEROL MADE BY THE LIVER. PROPAFENONE HCL ER CAP 325MG 60 NDC CODE:68462040960 FDA PRODUCT CODE NO.: 63 E C F 28 MNBU0385164 001 H. T. S NO.: 3004.49.00.10 ANDA NO.: 205268 THERAPEUTIC E USE: -AN ANTIARRHYTHMIC AGE NT IT IS USED TO TREAT IRREGU LAR HEARTRHYTHM AND CAN SLOW RAPID HEARTBEATS SODIUM PH ENYLBUTYRATE TAB 500MG 250 ND C CODE:68462085320 FDA PRODUC MNBU0385164 001 T CODE NO.: 65 C D A 09 H. T . S NO.: 3004.90.1000 ANDA N O.: 216462 THERAPEUTICE USE: :#UREA CYCLE DISORDER AGENT TACROLIMUS OINT 0.1% 30GM NDC CODE:68462053435 FDA PROD UCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 AND MNBU0385164 001 A NO.: 210393 THERAPEUTICE US E: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT U SED FOR THE TREATMENT OF MOD ERATE-TO-SEVERE ATOPIC DERMAT ITIS (ECZEMA). POTASSIUM C L ER CAP 10MEQ 500 NDC CODE:6 8462035705 FDA PRODUCT CODE N MNBU0385164 001 O.: 65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO.: 202 868 THERAPEUTICE USE: - TREA TMENT OR PREVENTION OF HYPOKA LEMIA S/BILL NO: 4000061 D T: 04.01.2023 S/BILL NO: 4000 068 DT: 04.01.2023 S/BILL NO: 4000062 DT: 04.01.2023 C MNBU0385164 001 OMMERCIAL & CUSTOM INVOICE NO. F22387001813 DT. 31.12.2022 F22387001820 DT. 31.12.2022 F22387001829 DT. 31.12.2022 N ET WT.1454.79 KGS 06 DATA LOG GERS HUMIDITY:65% SET TEMPER ATURE : +18 DEGREES TEMPERATU RE RANGE : +15 DEGREES TO +25 MNBU0385164 001 DEGREES NOTIFY PARTY:2 GLENM ARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

36 PALLETS 2369 CARTONS PHARMACEUTICALS AS UNDER PO TASSIUM CL ER CAP 10MEQ 100 N DC CODE:68462035701 FDA PRODU CT CODE NO.:65 R C F 14 H. T . S NO.: 3004.90.92.90 ANDA NO.:202868 THERAPEUTICE USE: TLLU1226750 001 - TREATMENT OR PREVENTION OF HYPOKALEMIA DILTIAZEM HCL ER CAP 12HR 60MG 100 NDC COD E:68462085001 62 O C B 24 30 04.49.00.10 212317 FOR THE T REATMENT OF HYPERTENSION. BISOPROLOL-HCTZ TAB 10/6.25MG 30 NDC CODE:68462088030 FDA TLLU1226750 001 PRODUCT CODE NO.: 62 O D A 18 H. T. S NO.: 3004.40.00.20 ANDA NO.: 215995 THERAPEUTIC E USE: BISOPROLOL FUMARATE AN D HYDROCHLOROTHIAZIDE TABLET S ARE INDICATED IN THE MANAG EMENT OF HYPERTENSION. BIS OPROLOL-HCTZ TAB 5/6.25MG 100 TLLU1226750 001 NDC CODE:68462087901 FDA PRO DUCT CODE NO.: 62 O D A 18 H . T. S NO.: 3004.40.00.20 AN DA NO.: 215995 THERAPEUTICE U SE: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE TABLETS ARE INDICATED IN THE MANAGEME NT OF HYPERTENSION. CARVED TLLU1226750 001 ILOL TAB 25MG 500 NDC CODE:68 462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78- 251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST TACROLIMUS CAP 1MG 100 NDC CO DE:68462068601 HTS NO: 3004.9 TLLU1226750 001 0.92.15 FDA CODE : 64 T C E 0 8 ANDA NO.206662 THERAPEUTIC USE : TO PREVENT REJECTION O F A KIDNEY,HEART, OR LIVER T RANSPLANT TACROLIMUS OINT 0 .1% 60GM NDC CODE:68462053465 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49. TLLU1226750 001 00.50 ANDA NO.: 210393 THERA PEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATME NT OF MODERATE-TO-SEVERE ATO PIC DERMATITIS (ECZEMA). T ACROLIMUS OINT 0.1% 100GM NDC CODE:68462053494 FDA PRODUCT TLLU1226750 001 CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA N O.: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IM MUNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERA TE-TO-SEVERE ATOPIC DERMATITI S (ECZEMA). SIROLIMUS TAB TLLU1226750 001 1MG 100 NDC CODE:68462068301 FDA PRODUCT CODE NO.: 64 T C A 12 H. T. S NO.: 3004.90.9 2.15 ANDA NO.: 208691 THERAP EUTICE USE: TO PREVENT REJECT ION OF KIDNEY TRANSPLANTS. PRAVASTATIN SOD TAB 20MG 500 NDC CODE:68462019605 FDA PRO TLLU1226750 001 DUCT CODE NO.:-61 J C A 13 H . T. S NO.: 3004.90.92.20 AN DA NO.:-77-987 THERAPEUTICE USE:-HYPOLIPDAEMIC TACROLIM US CAP 1MG 100 NDC CODE:68462 068601 HTS NO: 3004.90.92.15 FDA CODE : 64 T C E 08 ANDA NO.206662 THERAPEUTIC USE : T TLLU1226750 001 O PREVENT REJECTION OF A KID NEY,HEART, OR LIVER TRANSPLAN T TACROLIMUS OINT 0.1% 30GM NDC CODE:68462053435 FDA PR ODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 A NDA NO.: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICA TLLU1226750 001 L IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF M ODERATE-TO-SEVERE ATOPIC DERM ATITIS (ECZEMA). S/BILL NO : 4018618 DT: 30.12.2022 S/B ILL NO: 4018616 DT: 30.12.202 2 S/BILL NO: 4018613 DT: 30. 12.2022 S/BILL NO: 4018619 DT TLLU1226750 001 : 30.12.2022 COMMERCIAL & CUSTOM INVOICE NO. F2238700 1778 DT. 29.12.2022 F22387001 780 DT. 29.12.2022 F223870017 83 DT. 29.12.2022 F2238700176 4 DT. 26.12.2022 NET WT.4414. 787 KGS 02 DATA LOGGERS SE T TEMPERATURE : +18 DEGREES TLLU1226750 001 NOTIFY PARTY:2 GLENMARK PHAR MACEUTICALS INC 750, CORPORAT E DRIVE, NEW JERSEY MAHWAH - 07430 USA

35 PALLETS 1773 CARTONS PHARMACEUTICALS AS UNDER E ZETIMIBE-SIMVA TAB 10/40MG 30 NDC CODE:68462032330 FDA PRO DUCT CODE NO.: 61 J D C 15 H . T. S NO.: 3004.49.00.10 AN DA NO.: 208699 THERAPEUTICE U MNBU0627400 001 SE: - THIS COMBINATION MEDICA TION IS USED TO HELP LOWER B AD CHOLESTEROL AND FATS (SUCH AS LDL, TRIGLYCERIDES) AND R AISE GOOD CHOLESTEROL (HDL) IN THE BLOOD. EZETIMIBE WORKS BY REDUCING THE AMOUNT OF CH OLESTEROL YOUR BODY ABSORBS F MNBU0627400 001 ROM YOUR DIET. SIMVASTATIN B ELONGS TO A GROUP OF DRUGS KN OWN AS "STATINS." IT WORKS BY REDUCING THE AMOUNT OF CHOLE STEROL MADE BY THE LIVER. EZETIMIBE-SIMVA TAB 10/80MG 30 NDC CODE:68462032430 FDA PR ODUCT CODE NO.: 61 J D C 15 MNBU0627400 001 H. T. S NO.: 3004.49.00.10 A NDA NO.: 208699 THERAPEUTICE USE: - THIS COMBINATION MEDIC ATION IS USED TO HELP LOWER BAD CHOLESTEROL AND FATS (SUC H AS LDL, TRIGLYCERIDES) AND RAISE GOOD CHOLESTEROL (HDL) IN THE BLOOD. EZETIMIBE WORK MNBU0627400 001 S BY REDUCING THE AMOUNT OF C HOLESTEROL YOUR BODY ABSORBS FROM YOUR DIET. SIMVASTATIN BELONGS TO A GROUP OF DRUGS K NOWN AS "STATINS." IT WORKS B Y REDUCING THE AMOUNT OF CHOL ESTEROL MADE BY THE LIVER. COLESEVELAM HCL TAB 625MG 180 MNBU0627400 001 NDC CODE:68462043318 FDA PR ODUCT CODE NO.: 62 B D A 13 H. T. S NO.: 3004.49.00.10 A NDA NO.: 203480 THERAPEUTICE USE: - ANTIHYPERLIPO PROTEIN EMIC. DILTIAZEM HCL ER CAP 12HR 120MG 100 NDC CODE:68462 056201 62 O C B 24 3004.49.0 MNBU0627400 001 0.10 212317 FOR THE TREATMEN T OF HYPERTENSION. DILTIAZ EM HCL ER CAP 12HR 90MG 100 N DC CODE:68462085101 62 O C B 24 3004.49.00.10 212317 FOR THE TREATMENT OF HYPERTENSIO N. CARVEDILOL TAB 25MG 500 NDC CODE:68462016505 FDA PRO MNBU0627400 001 DUCT CODE NO : 62 O C A 22 H . T. S NO.: 3004.90.92.20 AN DA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR AN TAGONIST EZETIMIBE-SIMVA TA B 10/40MG 90 NDC CODE:6846203 2390 FDA PRODUCT CODE NO.: 6 1 J D C 15 H. T. S NO.: 3004 MNBU0627400 001 .49.00.10 ANDA NO.: 208699 T HERAPEUTICE USE: :#LIPID LOWE RING AGENT CHLORPROMAZINE H CL TAB 10MG 100 NDC CODE:6846 2086101 61 T C A 04 3004.90. 92.40 212144 TO TREAT PSYCHO TIC DISORDERS SUCH AS SCHIZO PHRENIA OR MANIC-DEPRESSION MNBU0627400 001 IN ADULTS PIMECROLIMUS CREA M 1% 30GM NDC CODE:6846206093 5 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90 .92.45 ANDA NO.: 211769 THER APEUTICE USE: - AS SECOUND-LI NE THERAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC T MNBU0627400 001 RERTMENT OF MILD TO MODERATE ATOPIC DERMATITIS IN NONIMMU NOCOMPROMISED ADULT AND CHILD REN 2 YEARS OF AGE TACROLI MUS OINT 0.1% 100GM NDC CODE: 68462053494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO. : 3004.49.00.50 ANDA NO.: 21 MNBU0627400 001 0393 THERAPEUTICE USE: - TAC ROLIMUS IS A TOPICAL IMMUNOSU PPRESSIVE OINTMENT USED FOR T HE TREATMENT OF MODERATE-TO- SEVERE ATOPIC DERMATITIS (EC ZEMA). SIROLIMUS TAB 0.5MG 100 NDC CODE:68462068201 FDA PRODUCT CODE NO.: 64 T C A 1 MNBU0627400 001 2 H. T. S NO.: 3004.90.92.15 ANDA NO.: 208691 THERAPEUTI CE USE: TO PREVENT REJECTION OF KIDNEY TRANSPLANTS. CAR VEDILOL TAB 25MG 500 NDC CODE :68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO .: 3004.90.92.20 ANDA NO.:- MNBU0627400 001 78-251 THERAPEUTICE USE:-BET A- ADRENOACEPTOR ANTAGONIST COMMERCIAL & CUSTOM INVOICE NO. F22387001721 DT. 20.12.2 022 F22387001722 DT. 20.12.20 22 F22387001724 DT. 20.12.202 2 F22387001679 DT. 14.12.2022 S/BILL NO: 4018136 DT: 21.12 MNBU0627400 001 .2022 S/BILL NO:4018134 DT: 2 1.12.2022 S/BILL NO: 4018139 DT: 21.12.2022 S/BILL NO:4018 135 DT: 21.12.2022 NET WT. 4, 939.16 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RAN GE : +15 DEGREES TO +25 DEGREE MNBU0627400 001 S NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

17 PALLETS 956 CARTO NS PHARMACEUTICALS AS UNDER EZETIMIBE TAB 10MG 90 NDC CODE:68462022690 FDA PRODUCT CODE NO.: 61 J C A 15 H. T. S NO.: 3004.49.00.10 ANDA N O.: #078560 THERAPEUTICE USE: MNBU0631123 001 LIPID LOWERING AGENT EZET IMIBE TAB 10MG 500 NDC CODE:6 8462022605 FDA PRODUCT CODE N O.: 61 J C A 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: #07 8560 THERAPEUTICE USE: LIPID LOWERING AGENT NAPROXEN SO D TAB 550MG 100 NDC CODE:6846 MNBU0631123 001 2017901 FDA PRODUCT CODE NO. :-62 G C A 50 H. T. S NO.: 3 004.90.92.40 ANDA NO.:-78-314 THERAPEUTICE USE:-ANTI -INF LAMMATORY, ANALGESIC EZETIM IBE TAB 10MG 500 NDC CODE:684 62022605 FDA PRODUCT CODE NO. : 61 J C A 15 H. T. S NO.: MNBU0631123 001 3004.49.00.10 ANDA NO.: #0785 60 THERAPEUTICE USE: LIPID L OWERING AGENT RUFINAMIDE TA B 400MG 120 NDC CODE:68462071 408 61 M C A 99 3004.90.92.3 0 205075 TO USED WITH OTHER MEDICATIONS TO PREVENT OR CO NTROL SEIZURES (EPILEPSY) AS MNBU0631123 001 SOCIATED WITH LENNOX-GASTAUT SYNDROME (LGS PIMECROLIMUS CREAM 1% 60GM NDC CODE:68462 060965 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 30 04.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE: - AS SECOU ND-LINE THERAPY FOR THE SHORT MNBU0631123 001 -TERM AND NON-CONTINUOS CHRON IC TRERTMENT OF MILD TO MODE RATE ATOPIC DERMATITIS IN NO N- IMMUNOCOMPROMISED ADULT A ND CHILDREN 2 YEARS OF AGE PIMECROLIMUS CREAM 1% 100GM NDC CODE:68462060994 FDA PROD UCT CODE NO.: 61 S C J 04 H. MNBU0631123 001 T. S NO.: 3004.90.92.45 AND A NO.: 211769 THERAPEUTICE US E: - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-C ONTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DER MATITIS IN NON- IMMUNOCOMPRO MISED ADULT AND CHILDREN 2 Y MNBU0631123 001 EARS OF AGE TACROLIMUS OINT 0.1% 100GM NDC CODE:68462053 494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004. 49.00.50 ANDA NO.: 210393 TH ERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIV E OINTMENT USED FOR THE TREA MNBU0631123 001 TMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). COMMERCIAL & CUSTOM INVOICE NO. F22387001628 DT. 07.12.20 22 F22387001629 DT. 07.12.202 2 F22387001631 DT. 07.12.2022 F22387001632 DT. 07.12.2022 F22387001633 DT. 07.12.2022 MNBU0631123 001 NET WT. 1,931.60 KGS 11 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JE RSEY MAHWAH - 07430 USA S /BILL NO: 4017519 DT:08/12/20 22 S/BILL NO: 4017518 DT:08/ MNBU0631123 001 12/2022 S/BILL NO: 4017508 D T:08/12/2022 S/BILL NO: 4017 517 DT:08/12/2022 S/BILL NO: 4017514 DT:08/12/2022

33 PALLETS 1883 CARTONS PHARMACEUTICALS AS UNDER PO TASSIUM CL ER CAP 10MEQ 100 N DC CODE:68462035701 FDA PRODU CT CODE NO.:65 R C F 14 H. T . S NO.: 3004.90.92.90 ANDA NO.:202868 THERAPEUTICE USE: MNBU0289807 001 - TREATMENT OR PREVENTION OF HYPOKALEMIA BISOPROLOL-HC TZ TAB 2.5/6.25MG 100 NDC COD E:68462087801 FDA PRODUCT COD E NO.: 62 O D A 18 H. T. S N O.: 3004.40.00.20 ANDA NO.: 215995 THERAPEUTICE USE: BIS OPROLOL FUMARATE AND HYDROCHL MNBU0289807 001 OROTHIAZIDE TABLETS ARE INDI CATED IN THE MANAGEMENT OF H YPERTENSION. BISOPROLOL-HCT Z TAB 5/6.25MG 30 NDC CODE:68 462087930 FDA PRODUCT CODE NO .: 62 O D A 18 H. T. S NO.: 3004.40.00.20 ANDA NO.: 2159 95 THERAPEUTICE USE: BISOPRO MNBU0289807 001 LOL FUMARATE AND HYDROCHLOROT HIAZIDE TABLETS ARE INDICATE D IN THE MANAGEMENT OF HYPER TENSION. BISOPROLOL-HCTZ TA B 5/6.25MG 500 NDC CODE:68462 087905 FDA PRODUCT CODE NO.: 62 O D A 18 H. T. S NO.: 30 04.40.00.20 ANDA NO.: 215995 MNBU0289807 001 THERAPEUTICE USE: BISOPROLOL FUMARATE AND HYDROCHLOROTHIA ZIDE TABLETS ARE INDICATED I N THE MANAGEMENT OF HYPERTEN SION. TACROLIMUS OINT 0.1% 30GM NDC CODE:68462053435 FD A PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.5 MNBU0289807 001 0 ANDA NO.: 210393 THERAPEUT ICE USE: - TACROLIMUS IS A TO PICAL IMMUNOSUPPRESSIVE OINT MENT USED FOR THE TREATMENT O F MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). COMME RCIAL & CUSTOM INVOICE NO. F2 2387001459 DT. 17.11.2022 F22 MNBU0289807 001 387001460 DT. 17.11.2022 S/BI LL NO: 4016465 DT: 18.11.2022 S/BILL NO: 4016466 DT: 18.1 1.2022 NET WT. 3,437.68 KGS 02 DATA LOGGERS SET TEMPERA TURE : +18 DEGREES NOTIFY P ARTY:2 GLENMARK PHARMACEUTICA LS INC 750, CORPORATE DRIVE, MNBU0289807 001 NEW JERSEY MAHWAH - 07430 U SA

40 PALLETS 2208 CARTONS PHARMACEUTICALS AS UNDER TA CROLIMUS OINT 0.1% 60GM NDC C ODE:68462053465 FDA PRODUCT C ODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO. : 210393 THERAPEUTICE USE: - MNBU0189705 001 TACROLIMUS IS A TOPICAL IMMU NOSUPPRESSIVE OINTMENT USED F OR THE TREATMENT OF MODERATE -TO-SEVERE ATOPIC DERMATITIS (ECZEMA). PRAVASTATIN SOD TAB 80MG 90 NDC CODE:68462019 890 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004. MNBU0189705 001 90.92.20 ANDA NO.:-77-987 TH ERAPEUTICE USE:-HYPOLIPDAEMIC PRAVASTATIN SOD TAB 20MG 5 00 NDC CODE:68462019605 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.:-77-987 THERAPEUTIC E USE:-HYPOLIPDAEMIC PRAVA MNBU0189705 001 STATIN SOD TAB 80MG 500 NDC C ODE:68462019805 FDA PRODUCT C ODE NO.:61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: -77-987 THERAPEUTICE USE:-HY POLIPDAEMIC CARVEDILOL TAB 25MG 500 NDC CODE:68462016505 FDA PRODUCT CODE NO : 62 O MNBU0189705 001 C A 22 H. T. S NO.: 3004.90. 92.20 ANDA NO.:- 78-251 THER APEUTICE USE:-BETA- ADRENOAC EPTOR ANTAGONIST GABAPENTI N TAB 600MG 500 NDC CODE:6846 2012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 30 04.90.92.30 ANDA NO.:-77-662 MNBU0189705 001 THERAPEUTICE USE:-ANTICONVUL SANT AGENT PRAVASTATIN SOD TAB 20MG 500 NDC CODE:684620 19605 FDA PRODUCT CODE NO.:- 61 J C A 13 H. T. S NO.: 300 4.90.92.20 ANDA NO.:-77-987 THERAPEUTICE USE:-HYPOLIPDAEM IC PROPAFENONE HCL ER CAP 2 MNBU0189705 001 25MG 60 NDC CODE:68462040860 FDA PRODUCT CODE NO.: 63 E C F 28 H. T. S NO.: 3004.49.0 0.10 ANDA NO.:205268 THERAPE UTICE USE:AN ANTIARRHYTHMIC A GENT. IT IS USED TO TREAT IR REGULAR HEART RHYTHM AND CAN SLOW RAPID HEARTBEATS S/B MNBU0189705 001 ILL NO: 4016883 DT: 25.11.202 2 S/BILL NO: 4016889 DT: 25. 11.2022 S/BILL NO: 4016885 DT : 25.11.2022 S/BILL NO: 4016 888 DT: 25.11.2022 S/BILL NO : 4016887 DT: 25.11.2022 COMMERCIAL & CUSTOM INVOICE N O. F22387001500 DT. 23.11.202 MNBU0189705 001 2 F22387001501 DT. 23.11.2022 F22387001502 DT. 23.11.2022 F22387001503 DT. 23.11.2022 F22387001515 DT. 24.11.2022 N ET WT. 8,180.00 02 DATA LOGG ERS SET TEMPERATURE : +18 D EGREES NOTIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC 750, MNBU0189705 001 CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

39 PALLETS 2075 CARTONS PHARMACEUTICALS AS UNDER CA RVEDILOL TAB 25MG 500 NDC COD E:68462016505 FDA PRODUCT COD E NO : 62 O C A 22 H. T. S N O.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BE MNBU0507175 001 TA- ADRENOACEPTOR ANTAGONIST TACROLIMUS OINT 0.1% 60GM NDC CODE:68462053465 FDA PRO DUCT CODE NO.: 64 T C J 08 H . T. S NO.: 3004.49.00.50 AN DA NO.: 210393 THERAPEUTICE U SE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT MNBU0507175 001 USED FOR THE TREATMENT OF MO DERATE-TO-SEVERE ATOPIC DERMA TITIS (ECZEMA). CARVEDILOL TAB 25MG 500 NDC CODE:684620 16505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 300 4.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADR MNBU0507175 001 ENOACEPTOR ANTAGONIST COLE SEVELAM HCL TAB 625MG 180 NDC CODE:68462043318 FDA PRODUCT CODE NO.: 62 B D A 13 H. T. S NO.: 3004.49.00.10 ANDA N O.: 203480 THERAPEUTICE USE: - ANTIHYPERLIPO PROTEINEMIC. POTASSIUM CL ER CAP 10MEQ MNBU0507175 001 500 NDC CODE:68462035705 FDA PRODUCT CODE NO.: 65 R C F 1 4 H. T. S NO.: 3004.90.92.90 ANDA NO.: 202868 THERAPEUTI CE USE: - TREATMENT OR PREVEN TION OF HYPOKALEMIA CARVED ILOL TAB 25MG 500 NDC CODE:68 462016505 FDA PRODUCT CODE NO MNBU0507175 001 : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78- 251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST COMMERCIAL & CUSTOM INVOICE NO . F22387001530 DT. 26.11.2022 F22387001543 DT. 29.11.2022 F22387001554 DT. 29.11.2022 MNBU0507175 001 F22387001558 DT. 29.11.2022 F 22387001560 DT. 30.11.2022 S/ BILL NO: 4017127 DT: 30.11.202 2 S/BILL NO: 4017128 DT: 30.1 1.2022 S/BILL NO: 4017129 DT: 30.11.2022 S/BILL NO:4017131 DT: 30.11.2022 S/BILL NO:401 7130 DT: 30.11.2022 NET WT. 8 MNBU0507175 001 ,422.91 02 DATA LOGGERS S ET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHA RMACEUTICALS INC 750, CORPORA TE DRIVE, NEW JERSEY MAHWAH - 07430 USA

37 PALLETS 1933 CARTONS PH ARMACEUTICALS AS UNDER TACR OLIMUS CAP 0.5MG 100 NDC CODE :68462068501 HTS NO: 3004.90. 92.15 FDA CODE : 64 T C E 08 ANDA NO.206662 THERAPEUTIC U SE : TO PREVENT REJECTION OF MNBU4137295 001 A KIDNEY,HEART, OR LIVER TRA NSPLANT POTASSIUM CL ER C AP 10MEQ 100 NDC CODE:6846203 5701 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004. 90.92.90 ANDA NO.:202868 THE RAPEUTICE USE: - TREATMENT OR PREVENTION OF HYPOKALEMIA MNBU4137295 001 PRAVASTATIN SOD TAB 80MG 90 NDC CODE:68462019890 FDA PRO DUCT CODE NO.:-61 J C A 13 H . T. S NO.: 3004.90.92.20 AN DA NO.:-77-987 THERAPEUTICE USE:-HYPOLIPDAEMIC TACROLIM US OINT 0.1% 100GM NDC CODE:6 8462053494 FDA PRODUCT CODE N MNBU4137295 001 O.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210 393 THERAPEUTICE USE: - TACR OLIMUS IS A TOPICAL IMMUNOSUP PRESSIVE OINTMENT USED FOR TH E TREATMENT OF MODERATE-TO-S EVERE ATOPIC DERMATITIS (ECZ EMA). TACROLIMUS OINT 0.1% MNBU4137295 001 60GM NDC CODE:68462053465 FD A PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.5 0 ANDA NO.: 210393 THERAPEUT ICE USE: - TACROLIMUS IS A TO PICAL IMMUNOSUPPRESSIVE OINT MENT USED FOR THE TREATMENT O F MODERATE-TO-SEVERE ATOPIC MNBU4137295 001 DERMATITIS (ECZEMA). VORIC ONAZOLE TAB 50MG 30 NDC CODE: 68462057230 FDA PRODUCT CODE NO.:61 W C A 59 H. T. S NO.: 3004.90.92.10 ANDA NO.:2035 03 THERAPEUTICE USE: -USED T O TREAT FUNGAL INFECTIONS GABAPENTIN TAB 600MG 500 NDC MNBU4137295 001 CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO. :-77-662 THERAPEUTICE USE:-A NTICONVULSANT AGENT NAPROX EN SOD TAB 550MG 100 NDC CODE :68462017901 FDA PRODUCT CODE NO.:-62 G C A 50 H. T. S NO MNBU4137295 001 .: 3004.90.92.40 ANDA NO.:-7 8-314 THERAPEUTICE USE:-ANTI -INFLAMMATORY, ANALGESIC G ABAPENTIN TAB 600MG 500 NDC C ODE:68462012605 FDA PRODUCT C ODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.: -77-662 THERAPEUTICE USE:-AN MNBU4137295 001 TICONVULSANT AGENT GABAPEN TIN TAB 600MG 500 NDC CODE:68 462012605 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-66 2 THERAPEUTICE USE:-ANTICONV ULSANT AGENT POTASSIUM CL ER CAP 10MEQ 500 NDC CODE:684 MNBU4137295 001 62035705 FDA PRODUCT CODE NO. : 65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO.: 20286 8 THERAPEUTICE USE: - TREATM ENT OR PREVENTION OF HYPOKALE MIA COMMERCIAL & CUSTOM INV OICE NO. F22387001575 DT. 30. 11.2022 F22387001574 DT. 30.1 MNBU4137295 001 1.2022 F22387001573 DT. 30.11 .2022 F22387001572 DT. 30.11. 2022 F22387001578 DT. 30.11.2 022 F22387001579 DT. 30.11.20 22 F22387001580 DT. 30.11.202 2 F22387001587 DT. 30.11.2022 F22387001600 DT. 30.11.2022 F22387001597 DT. 30.11.2022 MNBU4137295 001 S/BILL NO: 4017247 DT: 02/12/2 022 S/BILL NO: 4017243 DT: 02 /12/2022 S/BILL NO: 4017244 D T: 02/12/2022 S/BILL NO: 4017 242 DT: 02/12/2022 S/BILL NO: 4017245 DT: 02/12/2022 S/BIL L NO: 4017250 DT: 02/12/2022 S/BILL NO: 4017246 DT: 02/12/2 MNBU4137295 001 022 S/BILL NO: 4017252 DT: 02 /12/2022 S/BILL NO: 4017253 D T: 02/12/2022 S/BILL NO: 4017 249 DT: 02/12/2022 NET WT. 6, 595.47 KGS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHA RMACEUTICALS INC 750, CORPORA MNBU4137295 001 TE DRIVE, NEW JERSEY MAHWAH - 07430 USA

37 PALLETS 1615 CARTONS PHARMACEUTICALS AS UNDER PR AVASTATIN SOD TAB 80MG 90 NDC CODE:68462019890 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA N O.:-77-987 THERAPEUTICE USE: MNBU0232210 001 -HYPOLIPDAEMIC PRAVASTATIN SOD TAB 20MG 500 NDC CODE:684 62019605 FDA PRODUCT CODE NO .:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.:-77-98 7 THERAPEUTICE USE:-HYPOLIPD AEMIC TOPIRAMATE ER CAP (Q) 150MG 30 NDC CODE:6846203703 MNBU0232210 001 0 3004.49.00.20 61 M C B 40 210278 TOPIRAMATE ER CAP ( Q) 25MG 30 NDC CODE:684620372 30 3004.49.00.20 61 M C B 40 210278 EZETIMIBE-SIMVA TA B 10/40MG 30 NDC CODE:6846203 2330 FDA PRODUCT CODE NO.: 6 1 J D C 15 H. T. S NO.: 3004 MNBU0232210 001 .49.00.10 ANDA NO.: 208699 T HERAPEUTICE USE: - THIS COMBI NATION MEDICATION IS USED TO HELP LOWER BAD CHOLESTEROL AN D FATS (SUCH AS LDL, TRIGLYC ERIDES) AND RAISE GOOD CHOLES TEROL (HDL) IN THE BLOOD. EZE TIMIBE WORKS BY REDUCING THE MNBU0232210 001 AMOUNT OF CHOLESTEROL YOUR B ODY ABSORBS FROM YOUR DIET. S IMVASTATIN BELONGS TO A GROUP OF DRUGS KNOWN AS "STATINS." IT WORKS BY REDUCING THE AM OUNT OF CHOLESTEROL MADE BY T HE LIVER. FROVATRIPTAN SUCC INATE TAB 2.5MG 9 NDC CODE:68 MNBU0232210 001 462069497 FDA PRODUCT CODE N O.:60 L C A 93 H. T. S NO.: 3004.90.92.28 ANDA NO.:204730 THERAPEUTICE USE: - USE:THE TREATMENT OF MIGRAINE HEADA CHES AND FOR SHORT TERM PREVE NTION OF MENSTRUAL MIGRAINE RANOLAZINE ER TAB 500MG 60 MNBU0232210 001 NDC CODE:68462031960 FDA PROD UCT CODE NO.: 61 D C B 02 H. T. S NO.: 3004.49.00.10 AND A NO.:211082 THERAPEUTIC USE: - IT IS AN ANTI-ANGINAL MED ICATION. IT WORKS BY IMPROVIN G BLOOD FLOW TO HELP THE HEAR T WORK MORE EFFICIENTLY. IT I MNBU0232210 001 S USED TO TREAT CHRONIC ANGIN A (CHEST PAIN). IT IS NOT FOR USE DURING AN ACUTE (EMERGE NCY) ATTACK OF ANGINA TACR OLIMUS OINT 0.1% 100GM NDC CO DE:68462053494 FDA PRODUCT CO DE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: MNBU0232210 001 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUN OSUPPRESSIVE OINTMENT USED FO R THE TREATMENT OF MODERATE- TO-SEVERE ATOPIC DERMATITIS (ECZEMA). PRAVASTATIN SOD T AB 20MG 500 NDC CODE:68462019 605 FDA PRODUCT CODE NO.:-61 MNBU0232210 001 J C A 13 H. T. S NO.: 3004. 90.92.20 ANDA NO.:-77-987 TH ERAPEUTICE USE:-HYPOLIPDAEMIC INDOMETHACIN ER CAP 75MG 6 0 NDC CODE:68462032560 FDA P RODUCT CODE: 62 GCE42 H. T. S NO.:3004.90.92.40 ANDA NO. 203501 THERAPEUTIC USE: INDO MNBU0232210 001 METHACIN IS USED TO RELIEVE P AIN, SWELLING, AND JOINT STIF FNESS CAUSED BY ARTHRITIS, GO UT, BURSITIS, AND TENDONITIS. IT IS ALSO USED TO RELIEVE PAIN FROM VARIOUS OTHER CONDI TIONS. THIS MEDICATION IS KNO WN AS A NONSTEROIDAL ANTI-IN MNBU0232210 001 FLAMMATORY DRUG (NSAID). ... THIS EFFECT HELPS TO DECREAS E SWELLING AND PAIN. INDOM ETHACIN ER CAP 75MG 90 NDC CO DE:68462032590 FDA PRODUCT CO DE NO.: 62 GCE42 H. T. S NO. : 3004.90.92.40 ANDA NO.: 20 3501 THERAPEUTICE USE: #INDO MNBU0232210 001 METHACIN IS USED TO RELIEVE P AIN, SWELLING AND JOINT STIFF NESS CAUSED BY ARTHRITIS, GOU T, BURSITIS AND TENDONITIS IT IS ALSO USED TO RELIEVE PAIN FROM VARIOUS OTHER CONDITIO NS.THIS MEDICATION IS KNOWN AS A NONSTEROIDAL ANTI-INFLA MNBU0232210 001 MMATORY DRUG THIS EFFECT HELP S TO DECREASE SWELLING AND P AIN. INDOMETHACIN ER CAP 75 MG 60 NDC CODE:68462032560 F DA PRODUCT CODE: 62 GCE42 H. T. S NO.:3004.90.92.40 ANDA NO.203501 THERAPEUTIC USE: INDOMETHACIN IS USED TO RELIE MNBU0232210 001 VE PAIN, SWELLING, AND JOINT STIFFNESS CAUSED BY ARTHRITIS , GOUT, BURSITIS, AND TENDONI TIS. IT IS ALSO USED TO RELIE VE PAIN FROM VARIOUS OTHER C ONDITIONS. THIS MEDICATION IS KNOWN AS A NONSTEROIDAL ANT I-INFLAMMATORY DRUG (NSAID). MNBU0232210 001 ... THIS EFFECT HELPS TO DEC REASE SWELLING AND PAIN. C OMMERCIAL & CUSTOM INVOICE NO. F22387001394 DT. 07.11.2022 F22387001395 DT. 07.11.2022 F22387001398 DT. 07.11.2022 F 22387001399 DT. 08.11.2022 F2 2387001400 DT. 08.11.2022 F22 MNBU0232210 001 387001403 DT. 09.11.2022 F223 87001405 DT. 09.11.2022 S/BIL L NO:4016038 DT:09.11.2022 S/ BILL NO:4016040 DT:09.11.2022 S/BILL NO: 4016041 DT:09.11.2

34 PALLETS 1695 CARTONS PHARMACEUTICALS AS UNDER PO TASSIUM CL ER CAP 10MEQ 100 N DC CODE:68462035701 FDA PRODU CT CODE NO.:65 R C F 14 H. T . S NO.: 3004.90.92.90 ANDA NO.:202868 THERAPEUTICE USE: MNBU4208911 001 - TREATMENT OR PREVENTION OF HYPOKALEMIA CARVEDILOL TA B 12.5MG 500 NDC CODE:6846201 6405 FDA PRODUCT CODE NO : 6 2 O C A 22 H. T. S NO.: 3004 .90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRE NOACEPTOR ANTAGONIST TACRO MNBU4208911 001 LIMUS OINT 0.1% 100GM NDC COD E:68462053494 FDA PRODUCT COD E NO.: 64 T C J 08 H. T. S N O.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE: - T ACROLIMUS IS A TOPICAL IMMUNO SUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERATE-T MNBU4208911 001 O-SEVERE ATOPIC DERMATITIS ( ECZEMA). TACROLIMUS OINT 0. 1% 60GM NDC CODE:68462053465 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.0 0.50 ANDA NO.: 210393 THERAP EUTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE O MNBU4208911 001 INTMENT USED FOR THE TREATMEN T OF MODERATE-TO-SEVERE ATOP IC DERMATITIS (ECZEMA). PI MECROLIMUS CREAM 1% 100GM NDC CODE:68462060994 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 ANDA N O.: 211769 THERAPEUTICE USE: MNBU4208911 001 - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-CONT INUOS CHRONIC TRERTMENT OF MI LD TO MODERATE ATOPIC DERMAT ITIS IN NONIMMUNOCOMPROMISED ADULT AND CHILDREN 2 YEARS O F AGE S/BILL NO: 4015597 D T: 31.10.2022 S/BILL NO: 401 MNBU4208911 001 5596 DT: 31.10.2022 S/BILL NO : 4015595 DT: 31.10.2022 COMMERCIAL & CUSTOM INVOICE NO. F22387001313 DT. 29.10.2 022 F22387001320 DT. 29.10.20 22 F22387001323 DT. 29.10.202 2 NET WT. 4,083.58 KGS 02 D ATA LOGGERS SET TEMPERATURE MNBU4208911 001 : +18 DEGREES NOTIFY PARTY :2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

37 PALLETS 1767 CARTONS PHARMACEUTICALS AS UNDER G ABAPENTIN TAB 600MG 500 NDC C ODE:68462012605 FDA PRODUCT C ODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.: -77-662 THERAPEUTICE USE:-AN MNBU0458240 001 TICONVULSANT AGENT TACROLI MUS OINT 0.1% 100GM NDC CODE: 68462053494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO. : 3004.49.00.50 ANDA NO.: 21 0393 THERAPEUTICE USE: - TAC ROLIMUS IS A TOPICAL IMMUNOSU PPRESSIVE OINTMENT USED FOR T MNBU0458240 001 HE TREATMENT OF MODERATE-TO- SEVERE ATOPIC DERMATITIS (EC ZEMA). PIMECROLIMUS CREAM 1 % 100GM NDC CODE:68462060994 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.9 2.45 ANDA NO.: 211769 THERAP EUTICE USE: - AS SECOUND-LINE MNBU0458240 001 THERAPY FOR THE SHORT-TERM A ND NON-CONTINUOS CHRONIC TRE RTMENT OF MILD TO MODERATE AT OPIC DERMATITIS IN NON-IMMUN OCOMPROMISED ADULT AND CHILDR EN 2 YEARS OF AGE PRAVASTA TIN SOD TAB 20MG 90 NDC CODE: 68462019690 FDA PRODUCT CODE MNBU0458240 001 NO.:-61 J C A 13 H. T. S NO. : 3004.90.92.20 ANDA NO.:-77 -987 THERAPEUTICE USE:-HYPOL IPDAEMIC PRAVASTATIN SOD TA B 20MG 500 NDC CODE:684620196 05 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.9 0.92.20 ANDA NO.:-77-987 THE MNBU0458240 001 RAPEUTICE USE:-HYPOLIPDAEMIC AMLOD-OLMESARTAN TAB 10/20M G 30 NDC CODE:68462056730 FD A PRODUCT CODE NO.: 62 C D A 68 H. T. S NO.: 3004.90.92.2 0 ANDA NO.: 207807 THERAPEUT ICE USE: -MEDICATION USED TO TREAT HIGH BLOOD PRESSURE AND MNBU0458240 001 CORONARY ARTERY DISEASE P RAVASTATIN SOD TAB 10MG 90 ND C CODE:68462019590 FDA PRODUC T CODE NO.:-61 J C A 13 H. T . S NO.: 3004.90.92.20 ANDA NO.:-77-987 THERAPEUTICE USE :-HYPOLIPDAEMIC COMMERCIAL & CUSTOM INVOICE NO. F2238700 MNBU0458240 001 1292 DT. 26.10.2022 F22387001 295 DT. 26.10.2022 F223870012 96 DT. 26.10.2022 F2238700129 7 DT. 26.10.2022 F22387001298 DT. 26.10.2022 S/BILL NO: 40 15284 DT: 26.10.2022 S/BILL N O:4015282 DT: 26.10.2022 S/BI LL NO:4015296 DT: 26.10.2022 MNBU0458240 001 S/BILL NO: 4015297 DT: 26.10.2 022 S/BILL NO: 4015298 DT: 26 .10.2022 NET WT. 6,439.20 KG S 02 DATA LOGGERS SET TEM PERATURE : +18 DEGREES